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ABSTRACT 
Background and objectives:- 
Objective of the study is to compare the effects of programmed labour 
protocol with the conventional labour protocol with regards to 
Adequacy of pain relief 
 Duration of labour  
Blood loss 
Maternal and neonatal adverse effects. 
Material and methods:- 
 This was a prospective, monocentric clinical trial. Total of 300 
women who attended Raja Mirasudhar Hospital, Thanjavur were included in 
the study. All were low risk gravid women. After they fit into the inclusion 
criteria, protocol of programmed labour was implemented on them as 
developed by Daftary SN etal and the labour outcome was studied. 
Partogram was plotted for all patients recommended by WHO. 
Results:- 
 In the study group 4.7% had outlet forceps delivery and 4% had 
caesarean section. Of the study group 26% had excellent pain relief as 
compared to 0% in control group. The mean rate of cervical dilation was 
3.71cm/Hr in the study group and 1.53cm/Hr in the control group. The mean 
duration of active phase 1st stage, 2nd stage, 3rd stage of labour were 
116.95mins, 21.23mins, 4.36mins respectively in the study group as 
compared to this 236.44mins, 23.57mins, 4.83mins respectively in the 
control group. Maternal and fetal outcome were comparable in both groups. 
Conclusion:- 
 Programmed labour protocol provides adequate labour analgesia, 
augments the process of labour thereby shortens the duration of labour 
reduces blood loss during labour without adverse maternal and fetal effects. 
Key words:- 
 Programmed labour; Labour analgesia; Partogram.  
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INTRODUCTION 
 
On recognition of the hard work that the parturient as well as the 
myometrium have to perform in order to deliver the fetus, human parturition 
has been termed as labour. 
Onset of regular, effective, painful, uterine contractions leading to 
progressive effacement and dilatation of the cervix, resulting in the 
expulsion of the fetus, placenta and the membranes is known as labour. 
These uterine contractions causing ischemia of myometrium is 
perceived as pain.Women seek assistance when they give birth. Midwifery 
or obstetrics   is the ‘oldest profession’1. Stress of the labour together with 
the labour pains exhausts the mother and prolongs the labour. When there is 
no medical contraindication, maternal request is enough to provide labour 
analgesia2. 
Ether was first used for pain relief in surgery by Morton in 1846. 
Obstetricians in United Kingdom used anaesthetic drugs for pain relief in 
labour. Dr. John Snow and Dr. James Young Simpson were the pioneers in 
this area. There were controversies, one group for and another group against 
labour analgesia. Detractors argued that it was violating God’s decree and 
were a dangerous adjunct for labour.  
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The first woman anesthetized for child birth was Fanny Longfellow in 
1847 for her third childbirth 3. Henry Wadsworth Longfellow administered 
the ether for his wife. Fanny Longfellow wrote, 
 “I had it for the good of every woman as no woman will have to 
suffer much pain. I’m sorry you all will think that I’m so naughty in trying 
ether. This is the greatest blessing of our age." 
Labour analgesia became popular only after Snow gave chloroform to 
Queen Victoria for her 8th childbirth in 1853. 
Dr. Oscar gave spinal cocaine to six parturient in their 2nd stage of 
labour for pain relief in 1900. That was the first documented regional 
anaesthesia in obstetrics.  
Dr.Hopkins did his first caesarean section using spinal anaesthesia in 
1902 in the united states.  Dr. Eugen Abuel reported his successful story of 
using epidural analgesia for a patient throughout her labour, the first such 
application in obstetrics.   
Pain relief during labour is need of the hour. The International 
Association for the study of pain (IASP) declared 2007-2008 as the “Global 
year against pain in women – Real Women, Real Pain’. Although epidural 
analgesia is excellent at pain relief, it demands technical expertise.  
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Programmed labour was developed by researchers to provide pain 
relief without adverse maternal and neonatal side effects. It includes 
judicious use of labour inducers, analgesics, antispasmodics and partogram. 
Partogram is used to monitor the progress of labour and to identify the 
dysfunctional labour earlier and to intervene at an appropriate time.  
This study was undertaken to compare the maternal and neonatal 
outcome of programmed labour protocol with the conventional labour. 
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AIMS AND OBJECTIVES 
 
Objective of the study is to compare the effects of programmed labour 
protocol with the conventional labour protocol with regards to 
Adequacy of pain relief 
 Duration of labour  
Blood loss 
Maternal and neonatal adverse effects. 
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REVIEW OF LITERATURE 
 
PHYSIOLOGY OF LABOUR 
 Series of events that take place in the genital organs in an effort to 
expel the products of conception into the outer world is called as labour.  
 
CASUATION OF LABOUR 
Exact trigger is not known-fetus or mother or both. Postulates are the 
loss of pregnancy maintenance factors and the synthesis of factors of labour 
inducers 
 Uterine distension 
 Feto-placental endocrine cascade 
 Hormones 
Uterine distension  
 Mechanical stretching effect on the myometrium by growing fetus 
and amniotic fluid increase the gap junction proteins –connexin 3, as well as 
the oxytocin receptors. Increased incidence of preterm deliveries in 
multifetal gestation and hydramnios can be attributed by this hypothesis. 
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Feto-maternal endocrine cascade4 
Human labor at term is a multifactorial physiologic event involving 
an integrated set of changes within the maternal tissues of the uterus 
(myometrium, decidua, and uterine cervix), which occur gradually over a 
period of days to weeks. Such changes include but are not limited to 
 An increase in prostaglandin synthesis and release within the 
uterus  
 An increase in the myometrial gap junction formation 
 Up-regulation of myometrial oxytocin receptors. 
Once the myometrium and cervix are prepared, endocrine or 
paracrine-autocrine factors from the fetoplacental unit bring about a switch 
in the pattern of myometrial activity from irregular to regular contractions.  
The fetus may coordinate this switch in myometrial activity through 
its influence on placental steroid hormone production, through the 
mechanical distention of the uterus and through the secretion of 
neurohypophyseal hormones and other stimulators of prostaglandin 
synthesis. The final common pathway toward labor appears to be the 
activation of the fetal HPO axis and is probably common to all viviparous 
species. 
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HORMONES 
OESTROGENS 
Oestrogens increase the excitability of the myometrial cell by 
decreasing their resting membrane potential. It stimulates the production of 
connexion-43 gap junction protein. It also stimulates the prostaglandin 
synthesis. Estrogen increases the oxytocin receptors and also sensitises the 
uterus for oxytocin to act. 
 
PROSTAGLANDINS 
It constitutes the final common pathway for the onset of labour. Its 
synthesis is stimulated by rise in estrogen, cortisol, uterine distension, 
increase in cytokines,(IL-6,TNF), infection, vaginal examination, separation 
or rupture of membranes. Gap junctions formation are enhanced by it. 
 
OXYTOCIN 
It is the major stimulus for the initiation of labour. Oxytocin receptors 
are higher in early labour than in advanced labour. The release of 
prostaglandins from the decidua is promoted by oxytocin. 
 
PHASES OF PARTURITION5.  
Parturition requires multiple transformations in both uterine and 
cervical function. It is divided into 4 overlapping phases. 
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Phase 1:  Uterine quiescence and cervical competence.  
Uterine muscle is kept unresponsive to natural stimuli and the ability 
of the myometrium to contract is held in abeyance. This phase comprise 
95% of the pregnancy. 
 
Phase 2: Phase of Activation: preparation for labour  
 It occurs during the last 6-8 weeks of pregnancy. Phase 2 is called 
uterine awakening / activation. Myometrial changes prepare it for labour 
contractions. Shift of phase 1 to phase 2 results from the alteration in the 
expression of contraction associated proteins (CAP) like oxytocin receptor, 
prostaglandin F receptor, and connexion 43. This increases the sensitivity to 
uterotonins and uterine irritability. 
  Cervix undergoes extensive remodelling for the transition from the 
softening to the ripening phase. Collagen fibrils are disorganised and the 
space between the fibrils increased in cervical ripening. Dermatan sulphate 
and chondroitin sulphate are replaced by hyaluronic acid, which imbibes 
water. Collagenases and leucocyte elastase decreases the collagen content of 
the cervix. 
 
Phase 3: Process of labour: Phase of Stimulation 
 Third Phase is synonymous with the active labour and  is divided into 
3 stages of labour. I stage is the stage of cervical effacement and dilatation. 
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II stage is the stage of fetal expulsion. III stage is the stage of placental 
separation and expulsion. 
 
Phase 4: Puerperium 
 Uterine involution occurs in phase 4. Uterus remains in a state of 
persistent contraction and retraction immediately after delivery and for an 
hour or so. Larger uterine vessels are compressed and thrombosis of their 
lumen occurs, thereby postpartum haemorrhage is prevented. Oxytocin 
facilitates maternal-type behaviour pattern and compression of uterine 
vessels. Uterine involution and cervical repair follow in a timely fashion. 
 
Stages of labour  
 
Prelabour or preparatory stage 
- Lightening or falling forward of the uterus occur. 
- Cervical canal undergo shortening gradually 
- False pains frequently occur 
Stage I : Begins with the onset of true labour pains to full cervical dilatation 
Three functional divisions of I stage of labour are: 
Preparatory division 
Dilatational division 
Pelvic division 
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Preparatory division  
  Components of the cervical connective tissue undergo changes 
considerably. Cervical dilatation is little. Sedation and analgesia can arrest 
this division of labour. 
 
Dilatational division   
Dilatation of cervix proceeds rapidly. This division is unaffected by 
sedation or analgesia. 
 
Pelvic division  
It commences with the deceleration phase of cervical dilatation. 
Cardinal movements occur during this division. 
Two phases of cervical dilation are, 
i) Latent Phase - Corresponds to preparatory Division 
ii) Active Phase - Corresponds to dilatation division 
 
Latent Phase 
  Begins with the onset of regular uterine contraction and ends with the 
cervical dilatation of 3-5cm.  Latent phase > 20 hr in primipara and > 14 hr 
multipara is defined as prolonged latent phase. 
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Active phase: It is further divided into 3 phases 
1. Acceleration Phase 
2. Phase of maximum slope 
3. Phase of Deceleration 
Primi  Multi 
  Mean duration  4.9 hr  2.5 hr  
  Rate of Cx dilatation 1.2 cm/hr 1.5 cm/hr 
 
II stage:  
It begins with the full dilatation of the cervix to the delivery of the 
fetus. It has 2 phases. 
 Propulsive phase 
 Expulsive Phase 
 
III stage of labour 
 It is the interval between the delivery of the fetus to the delivery of 
the placenta & membranes. 
Duration of III stage in 5-15 min 
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IV stage  
  Following the delivery of the placenta, 1st hour of the Pueperium is 
known as the 4th stage of labour. Vitals are monitored (BP, Pulse) every 15 
minutes to identify any postpartum haemorrhage at the earliest. 
 
Active Phase Disorders 
Active phase problems are divided into protraction disorder and arrest 
disorder by Friedman. Protraction is defined as the slow rate of cervical 
dilatation of <1.2cm per hour for nullipara and <1.5cm per hour for 
multipara or slow rate of fetal descent of <1cm per hour and <2cm per hour 
for nullipara and multipara respectively. Arrest of dilatation is defined as the 
complete cessation of dilatation for 2 hours, and arrest of descent as no fetal 
descent for 1 hour. 
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ACTIVE MANAGEMENT OF LABOUR6,7 
 
 To reduce the duration of labour and for earlier identification of   
dysfunctional labour, active management of labour concept was first 
implemented by O’ Driscoll and colleagues at the National maternity 
hospital in Dublin in 1968. 
 Active Management of labour includes patient education, a 
disciplined approach to labour diagnosis and management, indications for 
intervention and review of the outcomes. 
The goal is to achieve efficient uterine contractions thereby shorten 
the duration of labour to affect spontaneous delivery in primigravida6. 
Components of active management of labour are  
  Organizational component  
Medical component. 
A.ORGANIZATIONAL COMPONENTS 
a. Antenatal education regarding birthing process and approach to labour on 
admission. 
b. Daily physician assessment of all patients. 
c. Bedside support and supervision to ensure labour progression and to 
provide emotional support to patient and families.  
d. Peer review of effectiveness of the system.  
 14  
B.MEDICAL COMPONENTS 
a. Rigid inclusion criteria:  
  Only low risk term gravid women with cephalic presentation are actively 
managed. 
b. Strict diagnosis of labour: 
  Labour is defined as onset of regular painful uterine contractions with 
any one of the following, 
        a) Complete effacement of the cervix 
     b) Bloody show 
     c) Ruptured membranes 
c. Early Amniotomy 
  It is done to assess the volume & liquor colour, if liquor is scanty (or) 
meconium stained, intense surveillance is made and is not eligible for 
augmentation with high dose oxytocin. 
d. Ensuring labour progression by using partogram. 
e. High dose oxytocin  
   High dose oxytocin is used to correct dystocia at 6 mIU per minute, 
increased every 15mt to maximum 40 mIU per minute till there are 3-5 
contractions per 10 minutes.   
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  Wei S et al8 (2012) concluded that when early amniotomy and early 
oxytocin were used, there was modest decrease in the caesarean section rate 
when compared with standard care. 
Jose et al9 (1992) in his study of active management of labour observed 
that there are no serious maternal or neonatal adverse effects while dystocia 
was reduced with the resultant increase in spontaneous vaginal delivery. 
Pattinson et al 10(2003) in his study on aggressive management of 
labour, he used single line partogram and oxytocin was started when the line 
was crossed. He observed reduced caesarean section rate in nulliparas but 
there is need for intensive monitoring. 
 
Labour Pain 
The most severe pain the women experiences during her life time is 
the labour pain. It is influenced by emotional, motivational, cognitive, social 
and cultural circumstance11. Nulliparous women are more likely to 
experience severe pain than multiparous women. 
 Pain may be aggravated by anxiety, fear, maternal expectations and 
the mother’s state of preparation for delivery.  Maternal oxygen 
consumption, cardiac output and circulating catecholamine levels are 
increased.  Increased serum catecholamine may cause fetal tachycardia, 
bradycardia or dysfunctional uterine contractions. 
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Anatomy of labour pain      
I stage 
 - It is diffuse and poorly localised, cramping and visceral in nature. 
 - Uterine contractions and stretching of the cervix cause pain 
 - It can be blocked by paracervical plexus blockade. 
II stage 
 - Somatic pain.    
 - Pain is sharp and localised. 
This is due to the distension of the vagina, traction on pelvic 
structures, pelvic floor and the perineum. 
Mechanisms of Pain 
 There are two types of pain transmitted from the female reproductive 
tract, visceral and somatic. 
 Visceral pain is caused by the distension of the cervix and the lower 
uterine segment. Sympathetic visceral afferents transmit sensation to various 
plexuses and then to the lumbar sympathetic chain. From the sympathetic 
chain, impulses pass into the spinal cord through the tenth, eleventh, and 
twelfth thoracic and the first lumbar nerves. These must be blocked to gain 
relief from pain during the first stage of labour. Sensation, from the cervix is 
also transmitted via parasympathetic afferents along the second, third and 
fourth sacral nerves. 
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Somatic afferents transmit sensation from the vagina and the 
perineum in the later stages of labour. Impulses pass to the spinal cord via 
the pudendal nerve to the second, third and fourth sacral nerves. 
 Proposed theory: 
a. Hypoxia of the contracted myometrium 
b. Interlocking muscle bundles cause compression of nerve 
ganglia in the cervix and lower uterus 
c. Inflammatory changes of the uterine muscles. 
d. Stretching of the peritoneum overlying the fundus. 
e. Stretching of the cervix during dilatation. 
Peripheral pathways: 
o Nerve supply of the uterus involves T11, T12, frequently T10, 
L1 and L2 Segments. 
o Cervix supplied by the S2, S3 and S4. 
o The pain caused by stretch of the birth canal was transmitted 
through “sacral segments” 
o The pain from lower uterine segment and cervix is transmitted 
through the pelvic nerve and the S2, S3 and S4 spinal 
segments. 
o Nociceptive afferents → lumbar sympathetic chain → lower 
thoracic sympathetic chain which they leave by the rami 
communicantes associated with T10-L1 → pass through the 
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posterior roots of these nerves to make synaptic contact with 
inter neurons in the dorsal horn. 
o During latent phase, pain is limited to T11 and T12 
dermatomes. 
o As labour progresses to the active phase and uterine 
contractions become intense the pain in T11 and T12 
dermatomes become severe and spreads to the adjacent T10-L1 
dermatomes. 
o The distribution of T10-L1 dermatomes in the back overlies the 
lower three lumbar vertebra and the upper half of sacrum. 
 
Second and third stage of labour : 
 The amount of nociceptive stimulation decreases. 
 Contractions of the uterus and distension of lower uterine 
segment continue to cause pain. 
 In addition pressure of the presenting part on pain sensitive 
structures in the pelvis and distension of the outlet and 
perineum become new sources of pain. 
 Progressively greater distension causes intense stretching, 
tearing of fascia and pressure on skeletal muscles of the 
perineum. 
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 Perineal pain is sharp and localized to the regions supplied by 
the pudendal nerves. 
 
In the late part of the first stage and during the second stage, the 
parturient develop aching and cramping discomfort in the thigh due to 
stimulation of pain sensitive structures in the pelvic cavity including 
 Traction on the pelvic parietal peritoneum and the structures it 
envelops including uterine ligaments. 
 Stretching and tension of bladder, urethra and rectum. 
 Undue pressure on one or more roots of the lumbosacral plexus. 
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The thought of labor produces fear and anxiety in the women. Labour 
pain is associated with increase in cortisol, ACTH, epinephrine, nor-
epinephrine and endorphins, which produce maternal exhaustion and 
uteroplacental insufficiency leading on to fetal distress. Duration of the 
labour is prolonged. 
To alleviate the women of her sufferings, various labour analgesics 
have been tried. 
 
LABOUR ANALGESIA 
 
An ideal analgesic technique should therefore take into consideration 
maternal wishes and preferences, available expertise, support staff and 
facilities. Practices in various countries may vary from culture to culture. 
 
The technique used should be cheap, easy to administer, produce 
good and reliable relief from pain, but not impair consciousness or 
cooperation. It should be nontoxic to mother and fetus and should not 
produce cardio respiratory depression in the fetus. The technique must have 
no tocolytic action and should not delay labour.  
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NON PHARMACOLOGICAL METHODS 
 
They are noninvasive and safe but their efficacy is unproven16.  
Attempts to minimize the pain of labour non – pharmacologically first 
began in the early twentieth century. 
 Natural childbirth was pioneered by Grantly Dick – Read in 1932. He 
suggested that the pain of childbirth was brought about by fear and tension 
and recommended passive muscle relaxation to reduce the pain. 
 Psychoprophylaxis is a technique which involves educating the 
mother about the functioning of her body and the physiology of labour. It 
originated in Russia and was later popularized in France by Lamaze (Lamae 
1958). The aims of psychoprophylaxis were similar to those of natural 
childbirth but directed at blocking pain impulses from the uterus and 
perineum by conditioned reflexes. The establishment of conditioned reflexes 
involved an intensive training period. Unlike dick – Read, Lamaze did not 
rule out the use of analgesics in labour. Leboyer (1975) advocated a 
modification of natural childbirth and advised delivery in a dark and quiet 
place, with massage of the newborn and a warm bath for baby shortly after 
delivery. He claimed that this technique produced a happier and healthier 
neonate. 
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 Studies on these methods have shown mixed results, with some 
researchers finding that they resulted in decreased analgesic requirements, 
shorter labours and lower instrumentation rates. Others however found no 
differences from control groups. 
 Other techniques include simple emotional support from the patient’s 
partner or another labour companion, touch and massage, the application of 
hot or cold compresses, hydrotherapy and adoption of the vertical position. 
This last technique includes ambulation during early labour, use of the 
squatting position or a birthing chair, and may aid maternal comfort. 
 Some techniques require extensive preparation and antenatal training. 
These include biofeedback, acupuncture, hypnosis and transcutaneous 
electrical nerve stimulation (TENS). 
 
TRANS CUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)15 
2 pairs of electrodes were placed on either side of the vertebral 
column about 2 cm over the T10–L1 dermatomes and over S2-S4 
dermatome to provide analgesia for the first stage of labour and second 
stage of labour respectively. Local release of ß-endorphin and the blockade 
of pain transmission to the brain through stimulation of A-fibre are 
suggested theories for TENS analgesia.  
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In the comparative study of TENS versus tramadol in labour 
analgesia by Thakur Ratna and Patir Reka17 (2004), TENS had pain relief as 
good as tramadol with little side effects. 
MASSAGE 
Massage can be provided by anyone at anytime.  
Smith et al18 (2012) reported less pain during labour from massage 
when compared with usual care. 
BREATHING AND RELAXATION TECHNIQUE  
Smith et al 19 (2012) observed pain intensity during the latent phase 
and the active phase of labour were reduced with relaxation when compared 
with no treatment. Assisted vaginal deliveries were reduced, with increased 
satisfaction with pain relief. 
ACUPUNCTURE 
Acupuncture needles are inserted into the skin and manipulated 
manually or passing low dose current to get pain relief.  Analgesia is 
mediated through release of serotonin and encephalin or release of 
endorphins. Pain relief achieved is inconsistent and unpredictable. 
Non pharmacological agents are indicated in women refusing 
pharmacological agents in pregnancy but seeking for pain relief .These 
methods have little side effects but efficiency of pain relief is poor and 
unpredictable 
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PHARMACOLOGICAL METHODS OF  
LABOUR ANALGESIA 
 
Systemic Regional 
1. Inhalational methods  
2. Systemic analgesics  
Opioid analgesics 
(Meperidine, Morphine, Fentanyl, 
sufentanil, Alfentanil, Remifentanil)  
 Agonist- antagonist analgesics 
(Nalbuphine Butarphanol, Tramadol) 
Non opioid analgesics 
 Sedatives tranquilizers  
  (Barbiturates, Phenothiazine   
derivatives, Benzodiazepines) 
 Dissociative or amnesic drugs  
(Ketamine, Scopolamine)  
1.  Epidural analgesia-lumbar 
2. Combined spinal epidural 
3. Continuous labour analgesia 
4. Lumbar sympathetic block 
5. Alternative regional anaesthetic 
techniques  
Pudendal block. 
Para cervical block.  
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PHARMACOLOGICAL AGENTS 
 
On January 19, 1847 Sir James young Simpson first used ether and 
chloroform for labour analgesia.3.  
The most important consideration in pregnancy is that there are in fact 
two individuals receiving treatment : mother and baby. 
 Anesthetic requirements in the peripartum period include long periods 
of constant pain relief, and an increased depth of analgesia might be needed 
as labour progresses and pain increases. Instrumental delivery might 
necessitate even deeper levels of sensory blockade, and any analgesic 
technique used will have to accommodate a sudden need for expeditious 
delivery. 
Inhalational agents:  
 
Earlier ether, chloroform and methoxy flurane were used. They were 
used in subanaesthetic doses for labour analgesia maintaining 
consciousness. They readily cross the placenta and reach the equipotent 
concentration in fetus but rapidly excreted through fetal lungs. 
Ether has pungent odour and is irritant to the respiratory tract. It has 
strong emetic effect. It is explosive and cannot be used in modern times as 
electrocautery is extensively employed. Chloroform produces arrhythmias 
and liver damage.  
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 Nitrous oxide is a colourless, odourless non irritating gas but a low 
potent anaesthetic. As it is not metabolized in the body and removed by the 
lungs from the body, it is non toxic to brain, kidney and liver. 
Entonox is 50% nitrous oxide with oxygen. On inhalation it produces 
analgesia within 20-30 seconds with maximum effect after 45 seconds. 
Limitations for its use are technical difficulties in administration, 
scavenging and theatre pollution.  
Klomp et al20 (2012) reviewed 26 studies and reported that nitrous 
oxide have more side effects when compared with flurane derivatives or no 
treatment. Flurane derivates had better pain relief than nitrous oxide in first 
stage of labour. 
 
PARENTAL OPIOIDS  
Opiates help the patient to tolerate pain better, but do not provide total 
analgesia. Opioids can be given orally, intramuscularly, intravenously or 
subcutaneously, either as intermittent boluses or continuously as an infusion 
or via a patient – controlled analgesia pump. This last technique generally 
provides good analgesia at lower analgesic dosages, and gives great patient 
satisfaction. 
 Maternal side effects include nausea, vomiting, drowsiness, decreased 
gastric emptying, respiratory depression and dysphoria. 
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 Fetal effects include respiratory depression at birth, and decreased 
baseline variability in the fetal heart rate.  
Ullman et al21 (2010) Cochrane reviewed 54 studies and concluded 
that parental opioids have more adverse effects though they have  pain 
relief. Maternal satisfaction with parental opioids is moderate. There was no 
clear evidence of adverse effects of opioids on the newborn. 
 
Epidural anaesthesia 
Epidural analgesia provides the most effective form of pain relief 
devised so far for labour and delivery.  The mother is conscious and can 
participate in the birth process. Advantages:- 
 Good analgesia is achieved throughout the labour. 
 As she is conscious airway in maintained, and able to interact with 
others and with her baby immediately after delivery. 
 Postpartum exploration and episiotomy repair can be easily 
performed. 
 Levels of maternal catecholamine are lowered, which may result in 
improved uteroplacental perfusion and better uterine contractility. The 
hyperventilation due to pain is reduced, limiting the leftward shift of the 
oxygen dissociation curve caused by hypocarbia. 
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 If labour does not progress satisfactorily and a caesarean section 
becomes necessary, epidural analgesia can be converted to an anesthetic by 
deepening the sensorimotor block. Post – operative pain can also be 
addressed by leaving the catheter in situ and giving epidural opiates, alone 
or with a local anesthetic infusion of low concentration (for example, 0.25% 
bupivacaine or lower). 
 Fetal benefits include lack of the respiratory depressant effect of 
parenteral opioids, and less fetal hypoxia and acidosis. 
 Limitations of epidural analgesia in labour include the consequences 
of autonomic blockade and hypotension, a possible dural tap leading to post 
dural puncture headache, missed segments, and high and total spinal 
blockade. Motor blockade is another significant problem. 
Epidural analgesia provides effective pain relief but at the cost of 
increased instrumental deliveries 
Epidural analgesia mandates the service of trained anaesthesiologist. 
Developing countries like India, where it is not possible to provide epidural 
analgesia for all, programmed labour is a safe alternate option which can be 
provided by the attending obstetrician herself.  
Anim-somuah M and Smyth R22(2011) Reviewed 21 studies 
comparing Epidural with  any form of pain relief or no pain relief in labour 
concluded that Epidural analgesia is effective in pain relief in labour but at 
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increased risk of instrumental delivery. It has no impact on risk of LSCS 
and long term backache.  
Combined spinal epidural 
 In this technique spinal anaesthesia is provided through epidural 
needle. It is known as walking epidural. The patients have rapid onset of  
pain relief and profound analgesia lasting for 120 minutes and does not have 
motor blockade. Once the spinal block effect wanes, analgesia can be 
provided with the indwelling epidural catheter. 
Paracervical Block 
 Frakenhauser ganglion, which is lying posterolateral to cervicouterine 
junction is blocked by paracervical block. It is used for pair relief only is 
first stage of labour. It does not affect the progress of labour. It is used 
rarely. 
 Pudendal Block: 
 In pudendal block, the pudendal nerve is blocked before its division. 
The sensory innervations of the lower vagina, vulva, perineum and the 
motor innervations of perineal muscles and the external anal sphincter are 
carried by the pudendal nerve. It is used for satisfactory vaginal delivery and 
outlet forceps delivery. 
Novikova N and Cluver C23 (2012) reviewed 41 trials and concluded 
that local anaesthetic nerve blocks are effective for management of pain in 
labour than placebo, opioid and non-opioid analgesia. 
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PROGRAMMED LABOUR24 
Definition 
It is an indigenously developed protocol by Shirish Daftary and his 
colleagues in 2003 for labour management.  
Dual objectives are 
1. Providing optimum pain relief 
2. Optimizing obstetric outcome to reach the goal of safe motherhood. 
Programmed labour incorporates the 3 principles of active 
management of labour advantageously. Pain relief is given utmost 
importance in programmed labour. 
 
Concept of programmed labour rests on 3 piliars (Daftary etal 1993) 
1. Ensuring adequate effective uterine contractions     
      Active management of labour 
2. Providing pain relief  
Use of analgesics and antispasmodics 
3. Close monitoring of labour events 
Using partograph 
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Benefits of pain relief  
1. As the fear and anxiety in the mother is relieved, uteroplacental 
circulation is maintained thereby baby is protected against hypoxia. 
2. Maternal exhaustion is prevented by providing adequate rest and 
sleep. 
3. As the cervical dilatation is facilitated, duration of the labour is 
shortened. 
4. Less operative deliveries and cervical tears. 
5. As the duration of labour is shortened, intrapartum infections are 
reduced. 
DRUGS USED IN THE PROGRAMMED  
LABOUR PROTOCOL 
 
1. Injection oxytocin 2.5 U in RL(augmentation of labour).10 U IM for 
active management of  third stage of labour 
2. Injection pentazociine 6mg in dilution slow IV 
3. Injection tramadol 1mg/kg body weight  IM 
4. Injection Diazepam 2mg in dilution slow IV 
5. Injection Drotaverine hydrochloride 40mg IM, every 2 hours 
(maximum 120mg). 
6. Injection Ketamine 0.25 mg/kg body weight in dilution slow IV 
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OXYTOCIN25,26: 
 
It comes under category B 
Oxytocin is a nana peptide which is structurally similar to 
vasopressin. It was discovered by Sir Henry Dale in 1906. It was the first 
polypeptide to be synthesized and sequenced. In 1909, first pituitary extract 
was used in labor. 
 
Sensitivity and the number of oxytocin receptors increases in the 
uterus near term. G- Protein coupled oxytocin receptors mediates the 
response by phosphoinositide hydrolysis and IP3 mediated intracellular 
release of calcium ions and depolarization of muscle fibers and influx of 
calcium ions. 
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Oxytocin relaxes the lower uterine segment and increases the 
contractility of fundus and body of the uterus. Contractile response is 
contributed by the prostaglandin whose synthesis and release by the 
endometrium and decidua is increased by oxytocin.  
 
At higher doses basal tone increases, which at lower doses, uterus 
relaxes in-between the contractions. 
 
Side effects  
maternal hypotension 
reflex tachycardia 
water intoxication can occur when large doses are given along with                           
IV fluids.  
Fetal bradycardia and fetal heart rate decelerations can occur. 
 
Dosage 
2.5 units in Ringer Lactate as infusion- for augmentation during 
labour 
  10 units intramuscularly after delivery 
Buqq GJ, Siddiqui Fand Thornton JG27(2011) included eight studies 
in Cochrane database systemic review for comparing oxytocin with no 
treatment.  
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They concluded that the use of oxytocin was associated with the 
reduction of duration of labour. It does not decrease the caesarean rate. 
 
Mori et al28 ( 2011) observed that high dose oxytocin at starting and 
incremental dose of equal to or more than 4 MU per minute was associated 
with a significant increase in spontaneous vaginal birth and reduction is 
duration of labor and  caesarean section. 
 
 
PENTAZOCINE 
 
Pentazocine is a benzomorphan derivative, which comes under 
Category C. Pentazocine is a complex action opioid with marked “κ’ Kappa 
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receptor agonist and µ receptor weak antagonist. It is the first analgesia to 
be used with agonist and antagonist action.  
Though it undergoes extensive metabolism (oxidation and 
glucoronide conjugation) in the    liver, it is orally effective. Onset of action 
is within a minute when given intravenously and lasts for 4-6 hours and 
excreted in urine. Half life of the drug is 3-4 hours. 
Dosage 
30 mg intramuscularly 
In our protocol, we use 6 mg pentazocine diluted with distilled water 
and given slowly intravenously. 
 
Side Effects 
Maternal hypertension 
Tachycardia 
Sedation 
Dizziness 
Sweating 
Vomiting 
Fetal respiratory depression occurs at doses higher than 30 mg. 
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Elbourne D and Wiseman RA29 (2000) observed pentazocine and 
pethidine had similar pain relief and maternal satisfaction with pentazocine 
having less nausea and vomiting. 
 
TRAMODOL 
 
Tramadol is a Category  C drug. 
It is a centrally acting synthetic opioid analgesia relieving pain by 
opioid as well as other mechanism. It has very low affinity for Kappa 
receptors and low affinity for µ opioid receptor. It activates 
monoaminergic spinal inhibition of pain by inhibiting the reuptake of nor 
epinephrine and serotonin. It is metabolized in the liver. Half life of the 
drug is 3-5 hours and its duration of action is 4-6 hours. 
Dosage 
50-100 mg oral /slow IV/IM.  4-6 hourly (1 mg/kg). 
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Side Effects  
Dryness of the mouth 
Nausea 
Dizziness 
Sleepiness 
Sweating 
Neonatal depression occur at large repeated doses.  
 
Nagaria T and Acharya J30 (2006) when comparing tramadol and 
pentazocine for pain relief in labour observed that both drugs had no 
significant changes in fetal heart rate pattern or maternal cardio respiratory 
depression. Tramadol group had shortened duration of 1st stage of labour 
than that in pentazocine group. 
Suvonnakote et al31 (1986) and viegas et al32 (1993) observed that, 
neonate in the tramadol group has lower respiratory depressant effect than 
that in pethidine group. 
Tramadol, though an opioid analgesic, is safe for the mother and her 
baby and provide adequate pain  relief with an additional effect of reducing 
the duration of labour. 
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DROTAVERINE HYDROCHLORIDE 
 
This novel anticholinergic drug, smooth muscle antispasmodic comes 
under category B of FDA classifications. It is an isoquinolone derivative 
with the potent spasmolytic property. It inhibits the enzymes 
phosphodiesterase IV, which is turn increase cAMP and cGMP to produce 
in the liver with half of the drug excreted unchanged in the urine. 
 
Dosage 
40 mg oral / IV. Maximum 120mg. 
 
Side Effects  
 
Headache 
Dizziness 
Flushing 
Hypotension (intravenous injection) 
Constipation 
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Nausea 
 Tachycardia 
Dryness of the mouth 
It is safe for the fetus. 
 
Roy et al33 (2007) noted that Drotaverine hastens the cervical 
dilatation and thereby reduces the duration of active phase of I stage of 
labour. Drotaverine reduces the cervical tears and traumatic postpartum 
hemorrhage. 
 
Madhu et al 34(2010) observed that both valethamate and Drotaverine 
helps cervical dilatation and augments first stage of labour but not the 
second or third stage with Drotaverine having lesser adverse effects. 
Sharma et al 35(2011) and Mishra et al36 (2002) concluded similarly 
that drotaverine hastens cervical dilatation than valethemate with fewer 
adverse effects. It is safe for the baby.  
 
Meena Thapa et al37 (2007) differed slightly saying Drotaverine 
dilates the cervix rapidly in multigravida while in primigravida both 
Drotaverine and valethamate are equally effective in reducing the duration 
of labour. 
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Salma BN and Zaib-Un Haroon38 (2011) observed phlorogulcinol 
hastens cervical dilatation and decreases the duration of labour when 
compared with drotaverine. 
 
DIAZEPAM 
 
 
Diazepam, benzodiazepine group is category B drug. It is first 
introduced around 1960 as anti anxiety drug; It also has hypnotic and 
anticonvulsant action. It acts by facilitating inhibitory GABAergic (GABAA 
receptors) transmission.  
On slow intravenous injection, diazepam produces analgesia. It 
produces prolonged milder effect preceded by brief initial phase of strong 
action due to a 2 phase plasma concentration decay curve (distribution phase 
half-life 1 hour and elimination half life of 20-30 hours). It is due to the 
production of active metabolite.  
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Side effects  
Drowsiness 
Nausea 
Vomiting 
 poor neonatal suckling reflex, sedation and hypotonia in the fetus. 
 
KETAMINE 
 
(2-[0-chlorophenyl] – 2 methylamino cyclohexane) It comes in the 
strength of 10mg, 50mg, and 100mg ketamine base per milliliter of sodium 
chloride solution containing benzethonium chloride as preservative. 
 In 1962 ketamine was synthesized by Stevens corssen. Domino in 
1965 first used ketamine in humans. From 1970 it is in clinical use for 
surgical anesthesia, profound analgesia and rapid recovery with less 
prominent emergence reaction. Among the 2 isomers, dextro rotatory isomer 
is more potent but produces less stimulation of central nervous system and 
cardiovascular system. 
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Pharmacokinetics: 
 It is externally metabolized in the liver, first, it is demethylated to 
norketamine, then hydroxylated to hydroxynorketamine and finally 
undergoes glucoronide conjugation. 
 Peak plasma level is reached within 30 seconds to one minute on 
intravenous injection and within 5 minutes following intramuscular 
injection. It has distribution half life of 10minutes and elimination half life 
of 2 – 3 hours. 
 It is a  hallucinogen, induces dissociative anesthesia. Concomitant 
activation of the limbic system and the depression of the thalamo 
neocortical pathway cause functional and electrophysiological dissociation 
are stated as dissociative anesthesia. 
Dissociative anesthesia is characterized by profound analgesia, 
amnesia with light sleep, immobility and feeling of dissociation from one’s 
own body and the surroundings. Ketamine is available as racemic mixtures.  
It inhibits NMDA receptor noncompetitively and interferes with the 
transmission of pain in the spinal cord. It inhibits nitric oxide synthase. It is 
serotogenic and noradrenergic reuptake inhibitor. 
Dosage 
0.25mg/kg –Analgesia 
           0.5-1.5mg/kg - Anaesthesia 
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Side Effects  
Hypertension 
 Bradycardia 
Delirium 
Hallucination 
Hyper salivation 
 
Altissimi C39 (1979) observed that ketamine is nontoxic to the fetus 
and mother as tested with cardiotocography and blood gas analysis and 
suggested that ketamine is useful in labour analgesia.
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ACTIVE MANAGENT OF THIRD STAGE OF LABOUR 40 
AMTSL is evidence based low – cost intervention for preventing 
PPH. 
Routine use of active management of the third stage of labour is 
recommended by the International Federation of Gynaecologists and 
Obstetricians (FIGO) and the International Confederation of Midwives 
(ICM), as well as by WHO. 
 
 The FIGO–ICM definition  
1. use of a uterotonic immediately following delivery of the fetus  
2. Delayed cord clamping. 
3.  Controlled cord traction  
4. Fundal massage immediately after delivery of the placenta, followed 
by palpation of the uterus every 15 minutes for 2 hours to assess the 
continued need for massage. 
 
Oladapo OT etal41 (2009) on comparing the outcome of third stage of 
labour in parturient who received AMTSL with those who did not, observed 
no significant difference among them. 
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Uterotonic drugs: 
 Cochrane systemic review compared oxytocin and syntometrine in 
active management of third stage of labour and concluded that syntometrine 
had higher side effects like vomiting, hypertension. No other significant 
differences in maternal outcome were observed. 
 In a Cochrane review comparing oral misoprostol with oxytocin for 
AMTSL showed that oral misoprostol had more blood loss and shivering 
and elevated body temperature. Despite this, it is useful in low resource 
setting. 
 
Controlled cord traction: 42 
 Maternal risks are 
  Uterine inversion   
  Cord separation. 
 In 5 major randomized controlled trials on AMTSL versus expectant 
management, cord separation or uterine inversion had not been recorded. 
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PARTOGRAM43,44,45,46 
 
 The basis for the scientific study of the progress of labour was 
developed by Friedman (1954), who described it graphically by plotting the 
rate of cervical dilatation against time. 
 
 The resulting graph of cervical dilatation forms the basis of modern 
partogram, which now incorporates many relevant parameters related to 
labour, like the condition of the mother and the fetus in relation to each 
other chronologically on one page. These parameters include cervical 
effacement and dilatation, the descent of the presenting part (in fifths of the 
head palpable above the pelvic brim rather than the station in cm above or 
below the ischial spines), fetal heart rate (FHR), the frequency and duration 
of uterine contractions, the colour and quantity of amniotic fluid, maternal 
parameters such as temperature, pulse and blood pressure, and drugs used. 
 
The pictorial documentation of labour facilitates the early recognition 
of poor progress. Plotting of cervical dilation also enables prediction of the 
time of onset of the second stage of labour.  
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TYPES OF PARTOGRAPHS 
1. WHO partographs 
a. Includes latent phase of 8 hrs and alert line starts at 3 cm 
dilatation and action line at 4 hrs to the right of alert line. 
b.  Modified partograph in 2000 excluded the latent phase. 
c. Color coded Partograph 
i. Area left to alert – green – normal progress. 
ii. Right to action – red – dangerously slow progress. 
iii. Inbetween lines – amber – need for great vigilance. 
iv. Dilatation recorded and not descent. 
2. Other Partographs 
a. Round partogram – not commonly used. 
Second stage partogram – based on descent and position of fetal head. 
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MATERIALS AND METHODS 
SUBJECTS: 
   This study was conducted in the Department of Obstetrics and 
Gynaecology, Raja Mirasudhar Hospital from December 2011-August 2012. 
300 parturient women in their active phase of labour were included in the 
study. 
Inclusion criteria: 
- Age : 18-35 yeas 
- Primigravida  
- Gestational age : 37-41 weeks  
- Singleton gestation  
- Vertex presentation 
- Clear liquor  
- NST Reactive 
Exclusion criteria: 
- Elderly primi 
- Cephalopelvic disproportion 
- Medical complications in pregnancy  
- Hydramnios / IUGR 
- Multiple pregnancy  
- Antepartum Hemorrhage 
- Previous uterine surgeries  
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Methods of study: 
  Three hundred low risk parturient women satisfying the above 
criteria were included in the study. They were alternately allocated into 2 
groups. 
 
Group 1 
150 women received programmed labour protocol. 
 
Group 2 
150 women were observed expectantly  
The time when they entered into the active phase was marked as zero 
hour in the partogram. Partogram was plotted and progress of labour 
monitored in all the patients. Only liquid or semisolid diets were allowed to 
reduce nausea or vomiting.  
 
Group 1: STUDY GROUP: 
   All women were started an intravenous line of Ringer lactate at the 
rate of 15 drops per minute. If the uterine contraction are not adequate, 
oxytocin 2.5Units in Ringer lactate infusion were started at the rate of 12 
drops per minutes and increased every 15-30 minute to get effective uterine 
contractions (3-5 /10 minutes lasting 35-40 seconds) 
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1 ampoule of pentazocine 30mg in 1ml and 1 ampoule of diazepam 
10mg in 2ml is diluted with 7ml distilled water to get diluents of 10ml. 2ml 
of the diluents containing 6mg injection pentazocine and 2mg of injection 
diazepam is given slowly intravenously. Injection Tramadol 1mg/kg (body) 
is given intramuscularly. Injection drotaverine hydrochloride 40mg is given 
intravenously. 2nd hourly drotaverine is repeated till full cervical dilatation 
to a maximum of 3 doses. Drotaverine helps cervical dilatation and also pain 
relief. Antispasmodic and analgesics are synergistic. Injection Tramadol 
have longer duration of action and it takes care of mild to moderate pain. 
 
   On 7-8 cm dilatation of cervix, injection Ketamine 0.25 mg/kg body 
weight diluted with distilled water is given slowly intravenously over 10 
minutes. If needed injection ketamine is repeated after 30 minutes in the half 
of the above dose. 10 ml of 1% lignocaine is infiltrated locally before 
episiotomy if required. Injection oxytocin 10U IM is given within one 
minute of delivery of the baby, as per active management of III stage of 
labour. Blood loss is estimated by PPH drape/mop count.  
Pain relief score was asked by rupees scale method  
1.  No pain relief : score zero  
2. Mild pain relief: score one 
3. Moderate pain relief : score two 
4. Excellent pain relief: score three 
 51  
Control group: 
  All women were started an intravenous line of Ringer lactate.  If 
uterine contractions are inadequate, injection oxytocin 2.5U in 500ml of 
Ringer lactate is started at the rate of 12 drops per minute and titrated to 
achieve effective uterine contractions. 
 
On delivery of the baby, 10 units of oxytocin injection is given 
intramuscularly within one minute as per Active management of III stage of 
labour. Blood loss is estimated. 
 
Parameters studied are 
Mean duration of all 3 stages of labour  
1. Active phase of I stage 
2. II stage 
3. III stage 
 
Mode of delivery  
Pain relief score  
Blood loss 
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Maternal outcome  
Ability to cooperate at 2nd stage 
Ability to feed her baby at 30 minutes 
Maternal adverse effects 
Maternal satisfaction score 
Neonatal outcome 
Birth weight  
APGAR score at 1minute and 5 minute. 
NICU admission.  
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RESULTS OF THE STUDY 
 
TABLE: 1 
 
AGE DISTRIBUTION 
 
Age Study Control  
(n=150) (100%) (n=150) (100%) 
Below 20yrs 26 17.3% 23 15.3% 
21 to 25yrs 101 67.3% 100 66.7% 
26 to 30yrs 23 15.3% 23 15.3% 
31 to 35yrs 0 .0% 4 2.7% 
 
 
The mean age of the patients in the study group and the control group 
is 22.91 years and 23.18 years respectively. In the study group the age of 
patients ranged from 18-30 years and in the control group from 18-34years. 
Majority of the women in the study and the control group were 21-25 years.  
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TABLE :2 
GESTATIONAL AGE 
 
GESTATIONAL AGE 
IN DAYS 
Study Control 
(n=150) (100%) (n=150) (100%) 
259 to 266 40 26.7% 39 26.0% 
267 to 273 46 30.7% 47 31.3% 
274 to 280 43 28.7% 38 25.3% 
281 to 287 21 14.0% 26 17.3% 
 
Mean Gestational age of the patients in the study group and control 
group were 272.73 and 272.93 days respectively. 
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FIGURE:2 
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TABLE:3 
 
 
MODE OF ONSET OF LABOUR 
 
 Study Control 
Spontaneous 114 76.0% 125 83.3% 
Induced 36 24.0% 25 16.7% 
 
 
83 .3% of the control group and 76.0% of the study group had 
spontaneous onset of Labour. 
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TABLE:4 
 
RATE OF CERVICAL DILATATION 
 
Rate of cervical 
Dilatation Study Control 
             cm/hr 3.71 ±1.64 1.53±0.64 
 
 
 
The mean rate of cervical dilatation in the study and the control group were 
3.71cm/hr and 1.53 cm/hr respectively. 
 
 
FIGURE: 4   
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TABLE:5 
 
 
DURATION OF 3 STAGES OF LABOUR 
 
 
Duration 
(min) 
Study control 
mean SD mean SD 
Active phase 
I stage 116.95 45.679 236.44 90.933 
II stage 21.23 9.292 23.57 12.404 
III stage 4.36 .979 4.83 1.589 
 
The mean duration of active phase of I stage of labour in the study 
and the control group were 116.95 min (1.95hr) and 236.44 min (3.94 hr) 
respectively. The mean duration of II stage of labour in the study group and 
control group were 21.23 & 23.57 min respectively. Mean duration of the III 
stage of labour in the study group and the control group were 4.36min and 
4.83min respectively.  
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FIGURE: 5 
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TABLE:6 
 
 
TOTAL DURATION OF LABOUR 
 
 Study Control 
Mean (min) 144.92 ± 55.799 263.59 ± 99.928 
 
 
Total duration of labour in the study and the control group were              
144.92 min (2.415 hr) and 263.59 min (4.39hr) respectively.                              
FIGURE: 6 
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TABLE: 7 
 
MODE OF DELIVERY 
 
MOD 
Study Control 
(n=150) (100%) (n=150) (100%) 
Normal delivery 137 91.3% 126 84.0% 
Outlet forceps 7 4.7% 10 6.7% 
LSCS 6 4.0% 14 9.3% 
 
91.3% of the women in the study group and 84% of the 
control group had normal vaginal delivery 4.7% of the study group 
and 6.7% of the control group have outlet forceps delivery. 4% of 
the study group and 9.3% of the study control group have 
undergone caesarean section. 
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FIGURE:8 
MODE OF DELIVERY - CONTROL GROUP 
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TABLE:8 
 
 
PAIN RELIEF SCORE 
 
 
 
Pain Relief score 
Study Control  
(n=150) (100%) (n=150) (100%) 
No pain relief 0 0% 50 33.3% 
Mild relief 21 14.0% 90 60% 
Moderate relief 90 60.0% 10 6.66% 
Excellent relief 39 26.0% 0 0% 
 
 
All the parturient in the study group had pain relief, out of which 26% had 
excellent pain relief and 60% had moderate pain relief. In the control group 
33.3% of the patients had no pain relief, 60% of them had mild pain relief.
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TABLE: 9 
 
 
 
INABILITY TO COOPERATE AT 2ND STAGE OF LABOUR 
 
Study Control 
5(3.3%) 4(2.7%) 
 
Five women in the study group were not able to cooperate in the 
second stage of labour. While in the control group four women did not 
cooperate because of maternal exhaustion.  
FIGURE: 10 
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TABLE: 10 
 
MECONIUM STAINED LIQUOR 
 
Study Control 
8 5.3% 10 6.6% 
 
 
5.3 percentage of the study group and 6.6 percentage of the control 
group had meconium Stained Liquor. 
FIGURE: 11 
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TABLE: 11 
BLOOD LOSS 
 
Study Control 
Mean(ml) SD Mean(ml) SD 
103.8 36.55 139.94 76.33 
 
 
Mean blood loss in the study group is 103.8ml, while in the control 
group it was 139.94ml  
FIGURE: 12 
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TABLE: 12 
 
 
 
MATERNAL COMPLICATION 
 
Maternal complication 
Study  Control 
(n=150) (100%) (n=150) (100%) 
No 111 74.0% 138 92% 
Nausea/Vomiting 15 10.0% 12 8.0% 
Tachycardia 9 6.0% 0 0% 
Drowsiness 11 7.3% 0 0% 
Dryness of mouth 7 4.7% 0 0% 
Hyper salivation 3 2% 0 0% 
 
Most common complication in the both groups was nausea 
and vomiting. No patient in either group had serious complication  
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TABLE:13 
 
MATERNAL SATISFACTION SCORE 
 
 
 
 
With the programmed labour protocol 100% of the women were 
satisfied. Majority of the women (61.3%) had good satisfaction with 25.3% 
of them had excellent satisfaction, nobody were unsatisfied. while in the 
control group 74% were unsatisfied. 
Maternal satisfaction 
Study Control 
(n=150) (100%) (n=150) (100%) 
Unsatisfied 0 .0% 111 74.0% 
Just satisfied 20 13.3% 37 24.7% 
Good satisfication 92 61.3% 2 1.3% 
Excellent satisfication  38 25.3% 0 .0% 
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FIGURE:14 
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TABLE:14 
 
BIRTH WEIGHT OF THE BABIES 
 
BW 
Study Control 
(n=150) (100%) (n=150) (100%) 
Below 2 Kg 7 4.7% 2 1.3% 
2.1 to 2.5 Kg 52 34.7% 63 42.0% 
2.6 to 3 Kg 74 49.3% 64 42.7% 
3.1 to 3.5 Kg 17 11.3% 21 14.0% 
 
 Majority of the babies in the study and control group are in the range 
of  2 to 3 kg .The mean birth weight of the babies in the study group is 
2.70±0.32 kg and in the control group 2.69±0.31 kg.  
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TABLE: 15 
 
NICU ADMISSION 
 
Study  Control 
13 15 
 
 13 Babies in the study group and 15 babies in the control group 
are admitted in NICU. All babies recovered well and discharged within 
24 to 48 hours. 
 
FIGURE: 16 
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TABLE: 16 
APGAR SCORE 
APGAR  Study Control  
 Mean(ml) SD Mean(ml) SD 
1 min 7.97 0.7 8.06  0.69 
5 min 8.75 0.48 8.82 0.46 
 
Mean apgar of the babies at 1 min and 5 min were 8 and 9 
respectively. 
FIGURE: 17 
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DISCUSSION 
  
67.3% of the women are in the age group of 21-25 years. Mean age of 
the women in both the groups are comparable. Mean age of the women in 
the study group was 22.91 ± 2.35 years as compared to 23 years in Meena et 
al47 (2006) study. 
 
 The mean gestational age of our study group is 272.73±7.316 days. 
This is similar to that observed in Meena et al47 (272.3 days) and shahida 
Mir et al48 studies (271.6 days).  
 
In my study, the study group had reduced duration of Active phase of 
I stage of labour (116.95±45.67) min, when compared with the control 
group (236.44 ± 90.33 min). Using student “t” test this difference was found 
to be significant statistically. [P value < 0.005]   
 
In Meena et al’s47 (2006) study, the mean duration of active phase of 
1st stage of labour is 165 min. When compared with the Daftary et al study24 
(240 min) we have almost half the duration. Duration of the active phase of 
first stage of labour is much lesser when compared with Meena et al47 
(2006) and veronica et al49 (2008) and Daftary et al24 (2009) studies. 
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 Duration of second stage of labour in the study and the control group 
is 21.23 ± 9.29 min and 23.57 ± 12.404 min respectively. It is not significant 
statistically when analysed with student “t” test. 
 
In Daftary et al24 and veronica et al 49studies, the duration of second 
stage of labour were 26min and 25 min respectively. This value is 
comparable to that observed in my study. In Meena et al 47study, the 
duration of second stage is 17.46minutes, this value is lower than that 
observed in my study. 
 
 The mean duration of third stage of labour in my study is 4.36 min in 
the study group and 4.83 min in the control group. This difference in 
statistically insignificant on using student “t” test.(> 0.005 ) This is similar 
to that observed  in Meena et al47 (4.94min) and Shahida Mir et al48 (4.8min) 
studies. In Daftary et al24 (2009) study, the duration of 3rd stage is still lower 
3.5 min. 
 
 In our study duration of all three stages of labour were shortened 
when compared with the control. But the difference is statistically 
significant in first stage of labour when studied with student “t” test. There 
is no statistically significant difference in the duration of II and third stage 
of labour. Meena et al47 study showed reduction is the duration of all 3 
stages of labour. 
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 Total duration of labour is 144.92 ± 55.799 min in the study group 
and 263.59 ± 99.928 min in the control group. This difference is statistically 
significant on analysing with student “t” test. 
 
  The study group had faster rate of cervical dilatation (3.71cm per 
hour) compared to the control group (1.53cm per hour). This difference was 
statistically significant when using student “t” test (p value < 0.005). 
 
 In Daftary et al 24(2009) study, the mean rate of cervical dilatation 
was 2.5cm per hour while veronica et al49 (2008) reported as 2.3cm per 
hour. The rate of cervical dilatation observed in my study is faster when 
compared with Daftary et al24 (2009) and Veronica et al49 (2008) studies. 
 
 114 women in the study group and 125 women in the control group 
had spontaneous onset of labour. Both groups were comparable regarding 
the mode of onset of labour. 
 
 Pain relief score of 2 or more is seen in 66% of the patients in the 
study group. Excellent pain relief is observed in 26% of the patients in the 
study group and none in the control group. When using chi-square test, there 
was statistically significant difference among the two groups.  
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Meena jyothi et al46 (2008) observed excellent pain relief in 54% of 
the study group, moderate pain relief in 32% and mild pain relief in 14%  
 
Shirish N Daftary et al24 (2009) observed excellent pain relief in 
labour in 26% and Prasertsawat et al50 (1986) in 24%, which is consistent 
with our study. 
 
91.3% of the women in the study group and 83% of the women in the 
control group progressed smoothly and had vaginal delivery without any 
interventions. 4% of the study group and 10% of the control group had 
caesarean section. On analysing the difference among them using chi-square 
test, they were not statistically significant. 
 
Our results are similar to that of Veronica et al’s 49 (2008) study. In 
Daftary et al 24 (2009) study only 65.5% of the women had vaginal delivery, 
while in Meena jyothi et al47 (2008) 98% of the women had vaginal 
delivery.  
When compared with Daftary et al24 (2009) study, our study had 
decreased assisted delivery (4.7%). But in Meena at al study47 (2008) 2% 
had assisted delivery with no caesarean section.   
 
4% of our parturient had caesarean section which was consistent with 
the veronica et al49 (2008) study. 
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Mode of delivery 
Mode of 
delivery 
Study Daftary24 Meena47 Veronica49 
Vaginal 
delivery 
91.3% 65.5% 98% 86.66% 
Forceps 4.7% 7% 2% 6.67% 
Ventouse 0% 15.5% 0% 0% 
LSCS 4% 12% 0% 6.67% 
 
 8 women in the study group and 10 women in the control group had 
meconium stained liquor. This was not statistically significant. 
 
 The commonest complication observed in both the study group and 
the control group was nausea and vomiting. Other complications noted in 
the study group were tachycardia, dryness of mouth. No patients in either 
group had serious adverse effects. 
 
Incidence of nausea and vomiting is similar to that in Meena jyothi et 
al (2008) and shahida M and Razia A48 (2011) studies. 
 
Our women in the study group (103.8 ml) had lesser blood loss 
compared to their controls (139.94ml). Using student “t” test, the difference 
was found to be statistically significant. In Meena et al study, the mean 
blood loss was 110ml, that was consistent with my study.   
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Daftary et al observed blood loss of only 60ml. In Veronica et al 
study, he observed blood loss of 75ml.        
                                                                                                                                                                                      
There was no neonatal mortality in either group. Neonatal outcomes 
were comparable in both the groups. There was no statistically significant 
difference between the study and the control group. 
 
All the babies had Apgar score of 7-9 at one and five minutes. 2 
babies in the control group had Apgar score of six at one minute and on 
resuscitation, they had Apgar score of 8-9 at 5 minutes. Mean Apgar of the 
babies at one and five minutes in both the groups were comparable. 
 
In their study, Sameer Dixit et al 51 (2005) reported Apgar score of             
8-10 in all neonates at one and five minutes. My study is consistent with his 
study. 
 
The mean birth weight of the babies in the study group and in the 
control group was 2.70 ± 0.32 kgs and 2.69 ± 0.31 kgs respectively. Using 
student “t” test, there was no statistically significant difference between 
them. 
 
Shahida M and Rafia A 48 (2011) reported the mean birth weight of 
the neonates 2.85kgs in the study group and 2.84kgs in the control group. 
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Comparison of Various Studies on Programmed Labour 
 
Outcome My Study Daftary24 Shahida48 Veronica49 Meena Jothi 47 
Vaginal 
Delivery 91.3% 65.5% 93% 86% 98% 
Duration of Labour 
1st stage  1.95Hrs 3.5Hrs 2.98Hrs 4Hrs 2.45Hrs 
2nd stage 21.23Mins 26Mins 29.6Mins 25Mins 17.46Mins 
3rd stage 4.36Mins 3.5Mins 4.5Mins 3 to 5 Mins 4.94 Mins 
Excellent 
Pain 
Relief 
26% 24% 37% 70% 54% 
Rate of 
Cervical 
Dilation 
3.71cm/Hr 2.5cm/Hr - 2.3cm/Hr  
- 
Blood loss 103 ml 60ml - 75ml 110ml 
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SUMMARY 
Study design 
Three hundred uncomplicated nulliparous women were included in 
the study when they were in active phase and were alternately allocated to 
two groups. One group (study) received programmed labour protocol while 
the other group (control) were observed expectantly. They were monitored 
for adequacy of labour analgesia, progress and duration of labour, maternal 
and fetal outcome. 
Statistical methods 
Value of significance was found using cross tabulations of the study 
with reference to pain relief score, rate of cervical dilatation, duration of all 
three stages of labour, maternal and neonatal outcome. 
 On comparing the age, gestational age, mode of onset of labour, there 
was no statistically significant difference between the study and the 
control group.  
 Regarding pain relief, in the study group 86%had pain relief score of 
two and above, while in the control group 6.66% had pain relief score 
of two. This was statistically significant. 
 The mean rate of cervical dilatation was 3.71cm per hour in the 
study group. It was significantly faster than that in the control group 
of 1.53 cm per hour. 
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 Total duration of labour in the control group (263.59 minutes or 4.39 
hour) is significantly higher that observed in the study group (144.92 
minutes or 2.42 hour). 
 9.3% of the women in the control group had caesarean section as 
compared to 4% in the study group. This is not statistically 
significant. 
 In the study group blood loss was 103.8 ±36.55 ml as against 139.94 
±76.33 ml, the difference was found to be statistically significant. 
 There were no serious maternal or neonatal adverse effects in either 
group. 
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CONCLUSION 
 
 Programmed labour is an easier, safer means for ensuring less painful 
delivery. 
 It reduces the duration of the labour without serious maternal and 
neonatal side effects 
 Pain relief is effective with minimal maternal side effects due to the 
drugs used. 
 Labour and childbirth are cherished by the mother and her family. 
 It can be adapted safely in all Maternity hospitals in low risk gravid 
woman. 
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ABBREVIATIONS 
 
1. LSCS- lower segment cesarean section 
2. HPO- Hypothalamo pituitary ovarian axis. 
3.  IL- interleukin 
4. TNF- tumour necrosis factor 
5. BP-blood pressure 
6. IM- Intramuscular 
7. IV- Intravenous 
8. cAMP – cyclic Adenosine Monophosphate 
9. cGMP- cyclic Guanosine Monophosphate 
10. GABA- Gama Amino butyric acid 
11. AMTSL- Active management of third stage of labour. 
12.NST-Non Stress test. 
13.PPH- post partum hemorrhage 
14. NICU- Neonatal intensive care unit 
PROFORMA 
 
Name      Age   IP No      UNIT  
DOA 
DO Delivery 
 
Menstrual H/O LMP   EDD   GA  
Marital H/O  Married since 
Obstetric H/O 
Past H/O  DM / HT /TB /ASTHMA / EPILEPSY / Heart Disease 
Family H/O  H/O / DM / HT 
 
O/E  GC 
 Pallor   Pedal edema   Pulse   BP 
 
 CVS   RS        
NST  - Reactive   Non - Reactive 
PAIN RELIEF SCORE 
Liquor Colour  Clear    Meconium 
Time      
Active phase of first stage of labour 
Full cervical dilatation 
Baby delivery time  
Delivery of the placenta 
 
Time Duration 
Active phase of first stage of labour 
Second stage of labour 
Third stage of labour 
 
MODE OF DELIVERY 
 Normal vaginal delivery 
 Outlet forceps with episiotomy 
 LSCS 
 MATERNAL OUTCOME 
 Ability to co-operate at 2
nd
 stage of labour   Yes  No  
 Ability to feed the baby at 30 min   Yes  No 
 Blood loss 
 Maternal complication 
 
NEONATAL OUTCOME 
 ALIVE / Dead 
 Male / Female 
 Baby weight 
 Apgar     1 min  5 min 
 NICU   Admission   Yes   No 
       if yes outcome 
 
MATERNAL SATISFACTION SCORE  
 
Annexure I : CONSENT 
 
I, Mrs……………………………w/o Mr………………… have been  
clearly explained in a language I best understand, about the procedure of the 
study which I will be undergoing through, its benefits, its complications,  
including the side effects of the drugs used in the study and also the 
possibility of the drugs affecting the baby and the need for repetitive per 
vaginal examinations.  
In my complete physical and mental sanity, I hereby give my full consent to 
get involved in the study.  
 
Place :     ……………………………….. 
Date:         Signature of the study subject  
 
 
 
…………………………………. 
 
                                                       Signature of witness  
      
WHO MODIFIED PARTOGRAPH 
 
 
 
 
 
 MASTER CHART – STUDY GROUP 
 
 
 
 
S.No 
 
 
Name 
 
 
IP No 
 
 
Age 
 
Pain 
Relief 
score 
 
GA 
Days 
 
RCD 
cm /hr 
Mode of 
onset of 
Labour 
Duration of labour( mins)  
 
MOD 
 
Liqour 
color 
Maternal Outcome Neonatal outcome  Maternal 
satisfactio 
n score 
Active 
phase  I 
stage 
 
II stage III 
stage 
Total 
Durati 
on 
ability 
to coop. 
II stage 
ability to 
feed 
30 mins 
Blood 
loss 
(ml) 
complicat 
ion 
BW 
(kg) 
Apgar 
1 min 
Apgar 
5 Min 
NICU 
Admissio 
n 
 
1 
 
SAVITHRI 191131 24 2 273 5.25 1 80 20 10 110 1 1 1 1 90 0 2.6 8 9 0 4 
 
2 
 
VIJAYBARATHI 192131 22 3 275 9.33 1 45 15 5 65 1 1 1 1 100 0 2.3 8 9 0 5 
 
3 
 
SASIKALA 191258 25 1 263 7.00 2 60 22 5 87 1 1 1 1 80 3 2.7 7 8 0 2 
 
4 
 
VETRISELVI 191393 27 2 273 2.33 1 180 15 4 199 1 1 1 1 95 4 2.8 7 8 0 4 
 
5 
 
SANGEETHA 191508 21 2 277 2.47 1 170 20 5 195 1 1 1 1 70 0 2.6 8 9 0 4 
 
6 
 
NAGALAKSHMI 191521 27 2 264 3.82 2 110 17 5 132 1 1 1 1 60 1 2.75 8 9 0 4 
 
7 
 
SENTHAMILSELVI 191654 21 2 271 6.46 1 65 17 4 86 1 1 1 1 85 0 2.5 8 9 0 4 
 
8 
 
SEETHA 191655 22 2 274 3.82 2 110 15 5 130 1 1 1 1 120 3 2.75 8 9 0 5 
 
9 
 
SASIREKHA 191653 22 2 260 3.00 1 140 15 5 160 1 1 1 1 65 0 3 8 9 0 4 
 
10 
 
PRIYANKA 191643 21 2 271 3.23 1 130 32 6 168 1 1 1 1 105 0 2.75 8 9 0 3 
 
11 
 
BANUMATHY 191407 21 1 271 3.00 1 140 14 4 158 1 1 1 1 110 0 3 7 8 0 5 
 
12 
 
DEEPA 191737 20 1 275 3.23 1 130 9 5 144 1 1 1 1 80 3 1.75 7 8 1 3 
 
13 
 
MAHARANI 191764 24 2 277 1.64 1 256 7 5 268 2 1 0 1 90 4 2.3 8 9 0 5 
 
14 
 
SARANYA 191879 22 2 278 3.50 1 120 20 5 145 1 1 1 1 90 1 3 8 9 0 4 
 
15 
 
SILAMBOLI 191753 22 2 270 3.50 2 120 20 4 144 1 1 1 1 110 0 2.25 7 8 0 5 
 
16 
 
SANGEETHA 192093 20 2 273 4.20 1 100 17 5 122 1 1 1 1 120 0 2.5 8 9 0 4 
 
17 
 
PETCHAYEE 192211 30 3 265 4.57 1 92 16 3.2 111.2 1 1 1 1 160 0 2.45 9 9 0 5 
 
18 
 
JEYACHITRA 192130 30 2 272 10.24 1 41 5 2 48 1 1 1 1 120 0 2.5 8 9 0 4 
 
19 
 
KAVITHA 192168 20 3 266 3.93 1 107 5 3 115 1 1 1 1 80 3 2.5 8 9 0 5 
 
20 
 
SANGEETHA 191998 25 2 280 4.67 1 90 28 7 125 2 1 0 1 70 2 3.25 7 8 0 4 
 
21 
 
SANTHI 192119 27 2 283 3.28 2 128 17 4 149 1 1 1 1 95 0 2.55 8 9 0 4 
 
22 
 
UMARANI 192349 25 3 261 10.50 1 40 14 4 58 1 1 1 1 60 1 2 7 8 0 5 
 
23 
 
PARAMESHWARI 192322 20 1 265 7.00 2 60 13 4 77 1 1 1 1 100 3 2.7 8 9 0 2 
 
24 
 
VIJAYASELVI 192336 27 1 271 7.50 1 56 14 4 74 1 1 1 1 120 0 2.5 9 9 0 3 
 
25 
 
SELVI 192339 22 1 274 4.67 2 90 13 4 107 1 1 1 1 110 0 2.75 9 9 0 3 
 
26 
 
VIDIHYA 192465 20 3 278 5.92 1 71 12 3.5 86.5 1 1 1 1 120 0 2.5 9 9 0 3 
 
27 
 
NAGASREE 192416 22 2 282 7.00 1 60 18 4 82 1 1 1 1 110 0 2.25 9 9 0 3 
 
28 
 
SIVASHANKARI 192360 27 3 272 4.67 1 90 23 5 118 1 1 1 1 100 3 2.7 9 9 0 4 
 
29 
 
MANJULA 192293 25 2 286 5.60 2 75 10 4 89 1 1 1 1 60 1 2.5 9 9 0 4 
 
30 
 
KAVITHA 192436 27 2 272 4.00 1 105 10 4 119 1 1 1 1 40 0 2.55 8 9 0 4 
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31 
 
RAJAKULI 192165 18 2 261 2.33 1 180 30 5 215 1 1 1 1 85 4 2.25 8 9 0 4 
 
32 
 
SUDHA 192485 23 1 271 2.63 1 160 15 3 178 1 1 1 1 80 0 2.7 9 9 0 1 
 
33 
 
KALA 192506 21 2 270 2.84 1 148 15 4 167 1 1 1 1 65 1 3 9 9 0 3 
 
34 
 
SARANYA 193223 21 2 259 3.00 1 140 12 3 155 1 1 1 1 60 3 2.6 8 9 0 4 
 
35 
 
ELAMATHI 193441 23 3 259 3.11 1 135 28 5 168 1 1 1 1 70 0 2.8 8 9 0 5 
 
36 
 
DURGA 193637 20 2 286 3.00 1 140 15 4 159 1 1 1 1 110 0 2.75 8 9 0 4 
 
37 
 
TAMILSELVI 106208 22 2 272 2.47 1 170 30 5 205 1 1 1 1 95 0 2.7 8 9 0 4 
 
38 
 
LAKSHMI 205949 19 2 278 3.11 1 135 20 6 161 1 1 1 1 170 0 3.3 8 9 0 3 
 
39 
 
ELAKIYA 206112 23 3 270 2.33 1 180 40 5 225 1 1 1 1 120 1 2.54 8 9 0 5 
 
40 
 
JANSIRANI 206023 20 2 280 2.63 2 160 40 5 205 1 1 1 1 60 0 3 8 9 0 4 
 
41 
 
KASTHURI 206325 20 2 280 2.80 2 150 33 5 188 1 1 1 1 70 0 2.5 8 9 0 4 
 
42 
 
VASANTHA 206029 24 2 284 3.11 1 135 30 4 169 1 1 1 1 80 0 2.75 8 9 0 5 
 
43 
 
SARANYA 206458 19 2 259 2.80 1 150 38 4 192 1 1 1 1 95 0 2.5 8 9 0 4 
 
44 
 
SASIKALA 206641 25 2 272 3.50 1 120 20 5 145 1 1 1 1 100 0 2.9 8 9 0 3 
 
45 
 
SUDHA 206785 19 2 280 2.80 1 150 20 5 175 1 1 1 1 110 2 2.8 8 9 0 4 
 
46 
 
SURYAKALA 206918 20 2 270 2.00 2 210 24 6 240 1 1 1 1 100 1 2.8 8 9 0 3 
 
47 
 
SENTHAMARAI 206947 22 2 280 7.00 1 60 22 4 86 1 1 1 1 75 0 2.9 8 9 0 2 
 
48 
 
MEENA 206921 23 2 272 3.50 1 120 36 4 160 1 1 1 1 85 0 2.8 8 9 0 3 
 
49 
 
SHANTHI 207083 20 2 280 2.63 2 160 20 4 184 1 1 1 1 110 0 2 8 9 0 3 
 
50 
 
KALAISELVI 207087 24 3 272 3.23 2 130 20 5 155 1 1 1 1 125 0 2.53 8 9 0 3 
 
51 
 
VANITHA 206696 22 2 270 3.50 1 120 45 5 170 2 1 0 1 120 1 3.2 9 9 0 4 
 
52 
 
SATHYAKALA 207334 24 3 280 2.71 1 155 25 5 185 1 1 1 1 100 0 2.7 8 9 0 5 
 
53 
 
GANGA 201418 25 2 259 3.82 1 110 25 4 139 1 1 1 1 95 0 2.8 9 9 0 4 
 
54 
 
GOWTHAMI 201682 18 3 266 2.90 1 145 25 5 175 1 1 1 1 60 0 2.5 9 9 0 5 
 
55 
 
PETCHIAMAL 202027 23 1 260 2.33 1 180 38 7 225 1 1 1 1 70 1 2.25 7 8 0 2 
 
56 
 
THANMOZHI 202117 23 2 280 2.21 2 190 29 4 223 1 1 1 1 60 0 2.7 7 9 0 4 
 
57 
 
GOWTHAMI 202263 22 2 272 4.94 1 85 15 5 105 1 1 1 1 70 0 2.5 8 9 0 4 
 
58 
 
NIRMALA 202385 21 2 266 3.00 1 140 28 5 173 1 1 1 1 80 0 2.5 8 9 0 4 
 
59 
 
VIMALA 202389 23 2 281 3.36 2 125 35 4 164 1 1 1 1 65 1 3 8 9 0 4 
 
60 
 
LAKSHMI 202399 22 2 270 3.11 1 135 23 5 163 1 1 1 1 110 0 2.7 9 9 0 4 
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61 
 
MUNESSWARI 202914 26 2 272 2.80 1 150 20 4 174 1 1 1 1 120 0 3.1 9 9 0 5 
 
62 
 
PREMA 202759 21 3 281 3.82 2 110 15 5 130 1 1 1 1 170 0 2.85 8 9 0 4 
 
63 
 
MAHALAKSHMI 203182 21 2 275 3.00 1 140 30 5 175 1 1 1 1 180 0 2.5 8 9 0 4 
 
64 
 
ELAKIYA 203174 23 3 280 2.80 1 150 60 5 215 1 1 1 1 110 4 3.3 8 9 0 5 
 
65 
 
MALARKODI 202833 21 2 276 3.50 2 120 40 3 163 2 1 0 1 120 0 2.5 9 9 0 4 
 
66 
 
SARANYA 203306 19 2 275 2.55 1 165 24 5 194 1 1 1 1 60 0 3 8 9 0 5 
 
67 
 
VAIDHEGI 203505 23 3 278 2.00 1 210 38 5 253 1 1 1 1 70 0 3.1 8 8 0 4 
 
68 
 
KANAGA 203222 22 2 264 3.23 1 130 39 5 174 1 1 1 1 115 0 2.6 8 9 0 5 
 
69 
 
JEYANTHI 203754 25 3 280 4.00 1 105 25 5 135 1 1 1 1 120 0 3.5 8 9 0 4 
 
70 
 
SATHYA 203915 28 3 270 4.00 1 105 17 4 126 1 1 1 1 100 0 2.5 8 9 0 5 
 
71 
 
PARVATHY 203865 27 2 260 3.23 1 130 35 4 169 1 1 1 1 110 0 2.5 8 8 0 5 
 
72 
 
ABIRAMASUNDARI 204105 24 3 275 4.94 1 85 20 4 109 1 1 1 1 120 0 3.3 8 8 0 4 
 
73 
 
MANIMEHALAI 203652 21 2 283 4.20 2 100 27 5 132 1 1 1 1 110 0 2.8 7 8 0 5 
 
74 
 
KALAIMANI 204193 22 1 277 3.00 1 140 15 5 160 1 1 1 1 120 0 2.5 7 8 0 4 
 
75 
 
ANANTHAVALLI 204203 21 2 282 3.82 1 110 25 3 138 1 1 1 1 110 0 2.75 8 9 0 3 
 
76 
 
GOWRI 204140 22 3 273 4.67 1 90 15 4 109 1 1 1 1 150 1 2.75 8 9 0 5 
 
77 
 
PUGHAZHENDHI 204458 21 2 276 4.67 1 90 22 4 116 1 1 1 1 130 3 3.2 8 9 0 4 
 
78 
 
AMUDHA 204523 25 3 280 2.71 1 155 30 4 189 2 2 1 1 180 0 3 7 8 0 4 
 
79 
 
SUGANTHI 204649 25 2 281 4.00 2 105 23 4 132 1 1 1 1 155 0 3.2 6 7 1 4 
 
80 
 
REKHA 204657 24 3 266 2.33 1 180 24 4 208 1 1 1 1 120 2 2.5 8 9 0 5 
 
81 
 
VEMBHU 204738 21 2 281 4.00 2 105 15 5 125 1 1 1 1 100 0 2.6 8 9 0 4 
 
82 
 
BOWTHINA 204751 20 2 280 2.80 1 150 20 4 174 1 1 1 1 120 0 2.5 7 8 0 3 
 
83 
 
ABINAYA 204783 23 2 280 3.11 1 135 25 4 164 1 1 1 1 110 0 2.7 8 9 0 4 
 
84 
 
MANJALMATHA 204828 21 3 266 4.20 2 100 15 4 119 1 1 1 1 100 0 2.5 9 9 0 5 
 
85 
 
SIVARANJANI 204871 24 3 275 3.00 1 140 25 4 169 1 1 1 1 90 0 2.75 8 9 0 5 
 
86 
 
TAMILSELVI 205008 20 3 282 3.82 1 110 20 4 134 1 1 1 1 120 0 2.5 8 9 0 4 
 
87 
 
REVATHY 205045 28 3 274 4.00 1 105 20 4 129 1 1 1 1 150 0 2.5 8 9 0 4 
 
88 
 
MAHESWARI 205232 26 3 266 5.25 1 80 15 4 99 1 1 1 1 100 0 2.8 7 8 0 5 
 
89 
 
SELVI 205310 25 1 266 4.00 1 105 20 45 170 1 1 1 1 150 0 2.6 7 8 0 2 
 
90 
 
RADHIKA 205332 21 2 261 4.42 1 95 28 4 127 1 1 1 1 60 0 3 7 8 0 4 
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91 
 
GUNAVATHY 205485 21 2 270 5.60 1 75 15 3.5 93.5 1 1 1 1 70 0 2.7 7 8 0 4 
 
92 
 
KAYALVIZHI 205499 20 2 281 4.42 2 95 22 4 121 1 1 1 1 120 2 2.75 8 9 0 4 
 
93 
 
SRIBALA 205581 23 2 273 5.25 1 80 18 4 102 1 1 1 1 110 0 2 8 9 0 4 
 
94 
 
KIRIJA 205584 22 2 262 7.00 1 60 20 4 84 1 1 1 1 60 0 2.8 8 9 0 4 
 
95 
 
KANAGA 205738 20 1 264 2.33 1 180 20 4 204 1 1 1 1 80 0 2.7 7 9 0 2 
 
96 
 
KARTHIGA 205752 25 2 261 3.65 1 115 16 4 135 1 1 1 1 150 1 2.5 8 9 0 3 
 
97 
 
SHARMILA 205889 24 1 266 2.00 1 210 30 4 244 1 1 1 1 90 2 3 8 9 0 2 
 
98 
 
PREMA 208393 23 1 284 4.67 2 90 17 4 111 1 1 1 1 85 3 3.3 9 9 0 2 
 
99 
 
SUMATHY 209627 23 2 286 4.20 2 100 15 3 118 1 1 1 1 100 0 2 9 9 0 3 
 
100 
 
VEERAJOTHI 223577 26 2 279 3.82 1 110 30 4 144 1 1 1 1 90 0 2 9 9 0 4 
 
101 
 
BHUVANESWARI 215589 19 2 280 4.00 1 105 25 4 134 1 1 1 1 100 0 2.75 8 9 0 4 
 
102 
 
SEETHA 217713 22 2 273 6.00 1 70 21 4 95 1 1 1 1 110 0 3.4 9 9 0 4 
 
103 
 
KANNAKI 218243 20 2 271 4.00 1 105 20 4 129 2 1 0 1 60 0 3 8 9 0 3 
 
104 
 
KALAISELVI 218317 22 3 264 3.50 1 120 27 3 150 1 1 1 1 95 4 2.4 7 8 0 5 
 
105 
 
SASIKALA 218369 25 22 280 3.36 1 125 15 3 143 1 1 1 1 120 0 3.3 9 9 0 4 
 
106 
 
SINDHUJA 218428 22 2 273 3.50 2 120 24 3 147 1 1 1 1 110 2 2.8 8 9 0 3 
 
107 
 
LALITHA 218455 23 2 266 4.42 1 95 18 4 117 1 1 1 1 95 3 2.6 8 9 0 3 
 
108 
 
GOWRI 218543 21 2 278 2.71 1 155 27 4 186 1 1 1 1 100 0 2.5 7 8 0 4 
 
109 
 
TAMILMANI 218792 28 2 279 NA 1   4 4 3 2 1 1 210 0 3.25 6 7 1 2 
 
110 
 
TAMILMANI 218849 21 2 273 3.36 1 125 15 4 144 1 1 1 1 100 0 3 7 8 0 4 
 
111 
 
JAYAPRIYA 218892 22 22 260 3.23 1 130 24 5 159 1 1 1 1 110 1 3 8 9 0 3 
 
112 
 
DEVI 218998 27 2 262 3.82 1 110 20 5 135 1 1 1 1 120 0 2.7 9 9 0 4 
 
113 
 
ANGELAMARY 219135 23 1 266 4.20 1 100 28 4 132 1 1 1 1 130 0 3 9 9 0 4 
 
114 
 
VASUMATHY 219241 21  273 3.00 1 140 19 5 164 1 1 1 1 120 0 3.3 8 9 0 2 
 
115 
 
CHITRA 219359 23 3 259 7.00 1 60 13 4 77 1 1 1 1 110 0 2.4 8 9 0 5 
 
116 
 
KASTHURI 219547 21 2 273 5.25 1 80 28 4 112 1 1 1 1 120 1 2.5 8 9 0 4 
 
117 
 
PARKAVI 219691 21 2 273 2.84 1 148 20 4 172 1 1 1 1 95 0 2.25 9 9 0 4 
 
118 
 
SUGASINI 219549 24 2 273 4.00 1 105 15 5 125 1 1 1 1 65 0 3 9 9 0 4 
 
119 
 
SHANTHI 219673 21 3 280 4.00 2 105 20 4 129 1 1 1 1 65 0 2.5 8 9 0 5 
 
120 
 
AMALA 219828 23 3 266 4.20 1 100 10 4 114 1 1 1 1 110 0 2.75 9 9 0 4 
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121 
 
RAMA 220212 22 3 276 3.50 1 120 19 4 143 1 1 1 1 70 0 2.5 8 9 0 5 
 
122 
 
SUSILA 220311 27 1 253 4.00 2 105 30 5 140 1 1 1 1 80 0 3 7 8 0 2 
 
123 
 
SELVARANI 220594 24 1 284 2.80 2 150 35 5 190 1 1 1 1 80 4 2.5 8 9 0 3 
 
124 
 
THENMOZHI 220820 22 1 268 3.11 1 135 28 4 167 1 1 1 1 110 0 2.5 7 8 0 2 
 
125 
 
KOUSALYA 221022 20 2 280 NA 1   3 3 3 1 1 1 120 2 2.5 7 8 1 1 
 
126 
 
GAYATHRI 222550 25 3 282 3.00 1 140 23 6 169 1 1 1 1 110 0 2.6 8 9 0 5 
 
127 
 
GEETHA 223348 24 3 274 2.47 1 170 18 5 193 1 1 1 1 120 0 2.5 7 8 0 5 
 
128 
 
MANGAYARKARASI 223677 28 2 280 4.00 1 105 17 3 125 1 1 1 1 130 0 225 8 9 0 4 
 
129 
 
DEVI 223872 20 2 286 4.67 2 90 37 4 131 1 1 1 1 110 2 2.6 9 9 0 4 
 
130 
 
KAVITHA 223912 29 1 278 2.71 2 155 21 8 184 2 1 1 1 15 0 3.2 9 9 0 2 
 
131 
 
JAMUNARANI 223962 22 3 275 2.33 2 180 40 5 225 1 1 1 1 95 0 2.5 8 9 0 5 
 
132 
 
VANITHA 224188 23 2 259 4.42 1 95 23 4 122 1 1 1 1 110 0 2.75 7 8 0 4 
 
133 
 
MAHALAKSHMI 224259 23 3 280 4.67 2 90 25 6 121 1 1 1 1 180 0 2.5 9 9 0 5 
 
134 
 
SUDHA 224528 23 2 274 NA 1   3 3 3 1 1 1 250 2 2.27 8 9 0 2 
 
135 
 
SELVIMARY 224603 26 2 270 4.20 1 100 17 5 122 1 1 1 1 110 0 2.75 8 9 0 3 
 
136 
 
SATHYA 224656 23 2 273 4.67 2 90 18 4 112 1 1 1 1 95 3 2.8 7 8 0 4 
 
137 
 
ANANTHALAKSHMI 224662 27 2 273 1.40 2 300 25 5 330 1 1 1 1 60 0 3.3 8 9 0 3 
 
138 
 
MAHASWARI 225121 25 1 278 NA 1   2 2 3 1 1 1 150 0 2.6 6 9 0 2 
 
139 
 
VASANTHI 225142 24 1 270 NA 1   3 3 3 1 1 1 250 0 3 8 8 1 2 
 
140 
 
MANIMOZHI 225276 25 2 281 3.82 1 110 20 4 134 1 1 1 1 110 0 3 8 9 0 3 
 
141 
 
SARAWATHY 225386 19 2 266 4.20 1 100 18 4 122 1 1 1 1 80 4 3 9 7 0 4 
 
142 
 
SUGANYA 225546 21 2 280 NA 1   3 3 3 1 1 1 260 0 2.8 7 9 0 3 
 
143 
 
KAVITHA 225614 23 3 266 3.23 1 130 25 5 160 1 1 1 1 70 0 2.5 7 9 0 5 
 
144 
 
VARALAKSHMI 225712 24 2 278 3.23 1 130 15 5 150 1 1 1 1 110 1 2.8 9 9 0 3 
 
145 
 
DURGADEVI 225717 20 3 262 3.82 1 110 21 4 135 1 1 1 1 65 0 3 8 8 0 5 
 
146 
 
MALATHY 225917 28 1 272 3.82 2 110 20 4 134 1 1 1 1 70 0 2 8 8 0 2 
 
147 
 
MARIAMMAL 225938 27 3 265 2.63 1 160 15 4 179 1 1 1 1 120 0 2.5 8 9 0 5 
 
148 
 
DHANALAKSHMI 226016 23 2 264 4.20 1 100 21 4 125 1 1 1 1 75 0 2.6 8 9 0 2 
 
149 
 
LATHA 226107 24 3 275 2.80 2 150 25 5 180 1 1 1 1 110 0 2.8 8 9 0 5 
 
150 
 
RAMAMANI 226327 22 3 274 3.23 1 130 20 4 154 1 1 1 1 75 0 2.5 8 9 0 5 
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1 POONGODI 191157 21 1 287 2.33 2 180 25 10 215 1 1 1 1 280 0 3.2 8 9 0 0 
2 MEENATCHI 191193 22 2 284 2.33 2 180 35 10 225 1 1 1 1 140 0 2.5 8 9 0 2 
3 ANITHA 191521 30 0 287 1.91 1 220 25 3 248 1 1 1 1 180 1 2.7 8 9 0 0 
4 DHANALAKSHMI 192176 21 1 288 1.75 2 240 19 6 265 1 1 1 1 350 1 2.2 9 9 0 1 
5 RENUKA 192926 23 1 281 2.00 2 210 16 4 230 1 1 1 1 180 0 3 9 9 0 1 
6 LOGANAYAKI 192842 20 0 280 1.75 1 210 30 6 246 1 1 1 1 95 0 2.8 7 9 0 2 
7 BHUVANESWARI 193377 23 1 279 1.87 2 225 28 6 259 1 1 1 1 110 1 2.5 7 9 0 1 
8 BHUVANESWARI 193545 20 2 269 1.29 1 325 13 5 343 1 1 1 1 210 0 2.75 8 9 0 2 
9 POTHUMPONNU 193527 25 1 270 1.68 1 250 46 4 300 1 1 1 1 105 0 2.5 8 9 0 1 
10 KAMALAVENI 201769 21 1 266 3.23 1 130 25 5 160 1 1 1 1 60 0 2.4 9 9 0 0 
11 REVATHY 201899 22 0 270 1.62 1 260 25 8 293 1 1 1 1 80 0 2.8 8 8 0 1 
12 DURGA 201989 21 1 266 1.65 2 255 17 6 278 1 1 1 1 50 0 2.6 8 9 0 0 
13 SHAMEEM 202491 22 1 261 2.00 2 210 20 7 237 1 1 1 1 70 0 2.4 8 9 0 1 
14 DEVI 202764 20 0 282 1.50 2 280 30 5 315 1 2 1 1 120 0 2.5 8 9 0 0 
15 ELAKIYA 202869 32 1 275 1.62 1 260 18 4 282 1 1 1 1 180 0 3.3 8 9 0 1 
16 JEYAKUMARI 203101 25 1 282 1.75 2 240 23 7 270 1 1 1 1 210 0 2.5 8 9 0 1 
17 LAVANYA 203304 26 1 280 1.47 1 285 25 3 313 1 1 1 1 170 1 2.5 8 9 0 2 
18 VELLAIYAMMAL 203106 27 0 272 1.22 1 345 25 6 376 1 1 1 1 60 0 2.45 8 9 0 0 
19 VIJI 203462 24 1 278 1.62 1 260 15 7 282 1 1 1 1 90 0 3.25 8 9 0 0 
20 MALATHI 203479 23 1 290 1.83 1 
 
21 6 27 1 1 1 1 280 0 3.25 8 8 0 0 
21 ANNUSHYA 203602 26 0 261 1.45 1 290 30 7 327 1 1 1 1 120 0 2.5 8 9 0 0 
22 SATHYA 203782 22 1 272 1.35 1 310 30 4 344 1 1 1 1 60 0 2.6 9 9 0 1 
23 SUGANYA 203890 21 1 264 1.32 1 315 38 7 360 1 1 1 1 80 0 2.3 9 9 0 1 
24 KANAGARANI 203940 23 1 281 1.11 1 330 44 6 380 1 1 1 1 120 0 2.9 8 9 0 1 
25 UMADEVI 203942 21 2 280 1.55 1 270 65 4 339 2 1 0 1 320 0 2 9 9 0 2 
26 PUNITHA 204118 25 1 274 1.08 1 390 20 4 414 1 1 1 1 90 0 2.3 8 9 0 1 
27 JEYALAKSHMI 204254 25 1 281 1.58 2 265 23 4 292 1 1 1 1 110 0 2.75 8 9 0 1 
28 MARIYAMMAL 204843 27 0 262 1.68 1 250 18 4 272 1 1 1 1 70 0 2.6 7 9 0 0 
29 JEEVAREKHA 204541 21 1 287 1.31 2 320 30 7 357 1 1 1 1 85 0 2.5 7 8 0 2 
30 SUBBULAKSHMI 204074 22 0 280 1.09 1 385 27 4 416 1 1 1 1 150 0 2.6 8 9 0 0 
31 KAMATCHI 204415 19 1 266 1.62 1 260 28 7 295 1 1 1 1 170 0 2.5 9 9 0 1 
32 SUGANYA 204745 26 0 260 1.20 1 350 30 7 387 1 1 1 1 210 0 2.7 8 9 0 0 
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33 MALARKODI 204929 18 0 266 1.55 1 270 25 4 299 1 2 1 1 95 0 2.5 9 9 0 0 
34 REVATHY 205181 27 0 280 1.22 1 345 35 4 384 1 1 1 1 100 0 2.1 9 9 0 0 
35 NITHYA 205261 21 1 270 1.53 1 275 40 3 318 1 1 1 1 90 0 2.5 8 9 0 0 
36 MENAKA 205573 19 0 269 1.25 2 335 17 4 356 1 1 1 1 110 0 2.7 9 9 0 0 
37 JANAKI 205582 21 0 272 1.62 1 260 15 7 282 1 1 1 1 125 0 2.6 8 9 0 1 
38 SUMATHY 205665 20 2 280 1.78 1 236 65 4 305 2 1 0 1 310 0 2.6 7 9 0 2 
39 BHUVANESWARI 205465 25 0 279 1.47 1 285 20 7 312 1 1 1 1 105 1 2.6 9 9 0 0 
40 MARTHAL 205907 23 0 282 1.40 2 300 35 6 341 1 1 1 1 110 0 2.8 8 9 0 1 
41 SASIREKHA 206056 23 0 276 1.29 1 325 23 7 355 1 1 1 1 95 0 2.8 8 9 0 1 
42 KRISHANVENI 206076 24 0 278 1.55 1 270 30 8 308 1 1 1 1 75 0 2.5 9 9 0 0 
43 MANVIZHI 206148 21 0 266 1.35 1 310 41 9 215 1 1 1 1 100 0 3.3 9 9 0 11 
44 NITHYA 206214 21 0 274 
 
1 
  
4 
 
3 2 1 1 250 0 2.5 9 9 0 0 
45 AMMU 206877 22 1 270 1.55 2 270 53 5 328 1 1 1 1 100 0 3.3 8 9 0 1 
46 RAJAKUMARI 206310 22 0 280 1.87 1 225 23 4 252 1 1 1 1 160 0 2.5 9 9 0 1 
47 BHUVANESWARI 206580 24 0 271 1.65 1 255 25 7 287 1 1 1 1 120 0 3.1 8 9 0 1 
48 MAHALAKSHMI 206334 23 0 270 2.05 1 205 16 4 225 1 1 1 1 280 1 3.5 8 9 0 3 
49 RAJAKUMARI 206693 21 0 285 1.31 2 320 34 6 360 2 1 1 1 110 0 2.68 8 9 0 1 
50 AYEESHA PARVE 206768 22 1 281 1.62 1 260 27 4 291 1 1 1 1 106 0 2.78 8 9 0 1 
51 KIRTHIKA 206624 20 1 271 1.55 1 270 70 4 344 2 1 0 1 105 0 2.51 8 9 0 1 
52 VIMALADEVI 206774 22 1 281 1.50 1 280 20 5 305 1 1 1 1 110 0 3 8 9 0 1 
53 VASANTHI 206935 22 0 260 2.15 1 195 24 5 224 1 1 1 1 90 0 3.8 9 9 0 0 
54 USHARANI 206938 24 1 271 
 
1 
  
6 
 
3 1 1 1 20 0 2.4 7 9 0 2 
55 SUMATHY 206955 25 1 262 1.65 1 255 35 4 294 1 1 1 1 60 1 2.5 9 9 0 1 
56 KRISHANVENI 207103 23 1 280 1.55 1 270 21 5 296 1 1 1 1 70 0 2.5 9 9 0 1 
57 PUNITHA 206982 22 1 272 1.71 1 245 25 4 274 1 1 1 1 110 0 2.5 9 9 0 0 
58 ANBUMATHY 207451 20 0 280 3.50 2 120 20 4 144 1 1 1 1 100 0 2.9 8 9 0 1 
59 VANITHA 207517 22 1 262 1.40 1 300 25 4 329 1 1 1 1 130 0 2.5 8 9 0 1 
60 USHA 217943 27 1 281 1.51 2 278 17 4 299 1 1 1 1 210 0 
 
8 9 0 1 
61 BHARATHI 218130 25 2 280 1.55 1 270 21 4 295 1 1 1 1 220 0 2.7 8 9 0 2 
62 RUKMANI 218101 24 0 273 1.95 1 215 23 4 242 1 1 1 1 110 0 2.5 8 9 0 0 
63 GEETHA 218315 22 1 259 1.53 1 275 18 4 297 1 1 1 1 70 0 2.4 8 9 0 1 
64 GOKILA 217632 28 1 271 1.79 1 235 50 4 289 2 1 0 1 275 1 2.6 8 9 0 2 
65 DEVI 218355 23 1 281 1.31 1 310 35 4 349 1 1 1 1 60 0 2.75 8 9 0 1 
  
 
S.No 
 
 
Name 
 
 
IP No 
 
 
Age 
 
Pain 
Relief 
score 
 
GA 
Days 
 
RCD 
cm 
/hr 
Mode of 
onset of 
Labour 
Duration  of labour( mins)  
 
MOD 
 
Liqour 
color 
Maternal Outcome Neonatal  outcome 
Materna
 
l satisfac 
tion 
score 
Activ 
e 
phase 
II 
stage 
III 
stage 
Total 
Duration 
ability to 
coop. 
II stage 
ability 
to feed 
30 mins 
Blood 
loss 
(ml) 
complic 
ation 
BW 
(kg) 
Apgar 
1 min 
Apgar 
5 Min 
NICU 
Admiss 
ion 
66 PAPATHY 218325 21 1 273 1.94 1 217 13 7 237 1 1 1 1 105 0 3.25 8 9 0 2 
67 MAHESWARI 218616 21 0 266 1.65 1 254 17 4 275 1 1 1 1 75 0 2.7 8 9 0 1 
68 SINDHUJA 218763 23 0 266 1.22 1 345 35 7 387 1 1 1 1 95 0 2.75 8 9 0 0 
69 KANIMOZHI 218867 22 1 274 1.56 1 269 16 4 289 1 1 1 1 125 0 2.5 9 9 0 1 
70 NITHYA 218144 19 1 280 
 
1 
  
5 
 
3 1 1 1 320 0 3 9 9 0 1 
71 DEVI 218998 27 1 270 1.52 1 277 13 4 294 1 1 1 1 135 0 2.7 9 9 0 1 
72 RAMYA 218842 20 1 284 1.26 2 333 28 4 365 1 1 1 1 105 0 3 8 9 0 2 
73 PRIYA 218973 20 0 264 1.52 1 276 24 5 305 2 1 1 1 240 0 2.5 7 8 0 1 
74 SUDHA 219149 27 1 271 1.65 1 254 29 4 287 1 1 1 1 110 1 2.3 8 9 0 0 
75 THANGAMANI 218698 22 0 280 1.65 1 255 15 5 275 1 1 1 1 85 0 2.6 8 9 0 1 
76 DURGADEVI 219183 27 1 266 1.83 1 230 20 5 255 1 1 1 1 120 0 2.75 8 9 0 0 
77 MANIMEHALI 219140 27 1 266 
 
1 
  
3 
 
3 2 1 1 280 0 2.735 6 7 1 1 
78 JOTHIMANI 219287 21 0 273 1.47 1 285 25 3 313 1 1 1 1 110 0 2.8 8 9 0 0 
79 KANIMOZHI 218928 23 1 273 1.95 1 215 15 4 234 1 1 1 1 120 0 3 8 9 0 2 
80 VANITHA 218794 27 0 273 1.87 1 225 27 8 260 3 1 1 1 105 0 3.1 9 9 0 2 
81 SAVITHA 219408 21 1 273 
 
1 
  
2 2 1 2 1 1 340 1 3.1 7 9 0 0 
82 SATHYA 219476 26 2 276 1.25 1 335 23 4 362 1 1 1 1 105 0 3.2 8 9 0 1 
83 SATHYA PRIYA 219280 21 1 274 1.65 1 255 28 3 286 1 1 1 1 95 0 3 8 9 0 1 
84 JEEVA 219712 25 1 280 
 
1 
  
2 
 
3 1 1 1 250 0 3 9 9 0 1 
85 PARIMALA 219245 25 1 273 1.40 1 300 20 5 325 1 1 1 1 200 0 2.2 9 9 0 2 
86 SAVITHA 219870 23 1 278 1.22 1 345 28 4 377 1 1 1 1 100 0 3 7 9 0 0 
87 SUCHITRA 219708 21 1 268 2.33 1 180 17 3 200 2 1 1 1 120 1 3 8 9 0 0 
88 SUBHA 218770 24 0 273 1.89 1 222 35 3 260 1 1 1 1 250 0 3.2 9 9 0 1 
89 PRIYA 219885 24 1 281 1.54 1 272 22 4 298 1 1 1 1 90 0 3.2 9 9 0 1 
90 REVATHY 219470 23 1 262 2.02 1 208 17 7 232 1 1 1 1 60 0 2.75 8 9 0 1 
91 PRIYANKA 219974 19 1 259 1.58 1 266 23 4 293 1 1 1 1 85 0 2.5 8 9 0 1 
92 MAHADEVI 220402 24 0 274 1.33 1 315 25 5 345 1 1 1 1 60 0 2.5 8 9 0 1 
93 ANJAMMAL 220486 30 1 273 1.40 1 300 25 9 334 1 1 1 1 75 0 2.4 7 9 0 2 
94 ARGAYARKANNI 220575 31 1 270 1.83 1 230 26 6 262 1 1 1 1 60 0 2.5 7 8 0 1 
95 VEERASAKTHI 220745 23 1 261 1.76 1 239 25 4 268 1 1 1 1 80 0 2.5 8 8 0 1 
96 NALINI 220847 21 0 280 1.49 1 281 23 4 308 1 1 1 1 70 0 2.7 9 9 0 1 
97 SHANTHI 220968 30 1 267 1.55 1 270 25 4 299 1 1 1 1 120 0 2.9 8 9 0 1 
98 VENMANI 221000 25 2 272 2.10 1 200 25 6 231 1 1 1 1 95 0 3.1 7 9 0 3 
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99 MALATHI 221060 22 1 270 1.65 1 255 33 4 292 1 1 1 1 60 0 2.5 8 8 0 1 
100 SHOBANA 221179 20 1 266 1.27 2 300 20 7 327 2 1 1 1 240 0 2.8 9 9 0 1 
101 REVATHY 221019 19 0 275 1.95 1 216 14 4 234 1 1 1 1 110 0 2.8 8 9 0 1 
102 RAMESHWARI 221108 24 1 266 
 
1 
  
2 
 
3 1 1 1 320 0 3.16 7 9 0 1 
103 LEELA 221471 23 0 271 1.24 1 340 35 4 379 1 1 1 1 125 1 2.5 9 9 0 1 
104 KARTHICKA 221516 19 0 272 1.71 1 245 15 4 264 1 2 1 1 60 0 2.4 8 9 0 1 
105 MEENA 221682 21 1 280 1.68 1 250 25 2 277 1 1 1 1 175 0 2.7 7 9 0 2 
106 CHANDRALEKHA 221771 34 1 270 1.53 1 275 39 4 318 1 1 1 1 120 0 3 8 9 0 1 
107 RATHIKA 221806 23 1 284 2.05 2 205 20 4 229 1 1 1 1 160 0 2.5 9 9 0 1 
108 DEVI 221866 26 1 284 1.58 2 265 21 6 292 1 1 1 1 170 0 3 9 9 0 1 
109 DEEPA 221915 26 1 260 1.33 1 315 35 7 357 1 1 1 1 110 0 2.7 8 9 0 2 
110 GUNASELVI 222027 22 1 265 1.91 1 220 13 6 239 1 1 1 1 80 0 2.2 9 9 0 0 
111 IMAIAZHAGI 222049 22 0 275 2.10 1 200 38 7 245 1 1 1 1 60 0 3 8 9 0 0 
112 SUBANESHWARI 222050 21 1 280 2.15 1 195 46 7 248 2 1 1 1 210 0 3.25 7 7 0 2 
113 VEERAMMAL 222064 27 1 274 
 
1 
  
3.5 
 
3 2 1 1 340 0 2.4 6 7 1 1 
114 NISHANTHI 222159 23 1 266 1.45 1 290 25 5 320 1 1 1 1 105 0 3.2 7 8 0 1 
115 RANJANI 222372 20 0 284 1.87 2 225 20 4 249 1 1 1 1 125 0 2.25 7 9 0 0 
116 THIRUMANASELV 222273 23 2 273 
 
1 
  
2 
 
3 1 1 1 320 0 2.2 8 8 0 1 
117 CHEVVANDHI 222487 22 1 271 1.45 1 290 25 4 319 1 1 1 1 125 0 2.4 7 9 0 1 
118 FATHIMAJEYARA 222555 23 1 264 1.65 2 255 17 5 277 1 1 1 1 105 0 2.4 7 9 0 1 
119 MARRIKANNU 222571 25 1 276 3.50 1 120 20 4 144 1 1 1 1 125 0 2.6 8 8 0 2 
120 DURGADEVI 222681 23 1 281 2.10 1 200 18 4 222 1 1 1 1 95 0 2.45 7 9 0 1 
121 DEVIKA 222884 21 1 274 1.55 1 270 25 4 299 1 1 1 1 60 0 3.2.9 8 8 0 1 
122 RAJALAKSHMI 222711 27 0 270 2.71 1 155 15 4 174 1 1 1 1 15 0 2.9 7 7 0 1 
123 SATHYA 222636 22 1 282 _ 1 
  
3 
 
3 2 1 1 310 0 2.26 7 9 1 1 
124 MARAGATHAM 222911 24 2 270 _ 1 
  
2 
 
3 1 1 1 250 0 2.5 8 9 0 2 
125 HEMALATHA 223042 21 1 263 2.10 1 200 15 6 221 1 1 1 1 110 0 2.5 8 9 0 1 
126 RAGINI 222961 20 1 282 1.66 1 360 37 8 405 1 1 1 1 150 0 2.5 8 9 0 1 
127 MEENAKA 222997 25 2 278 1.33 1 315 25 6 346 1 1 1 1 130 0 2.5 8 9 0 1 
128 VIJAYAKALAPRIY A  223009 32 1 273 1.83 1 230 35 5 270 1 1 1 1 180 0 2.75 9 9 0 0 
129 PICHIAMMAI 223794 25 0 272 1.62 1 260 25 4 289 1 1 1 1 130 0 2.5 8 9 0 1 
130 SASIKALA 223620 25 1 261 
 
1 
  
3 
 
3 1 1 1 250 0 3.05 8 9 0 1 
131 MAHESWARI 223812 21 0 259 1.53 1 275 27 4 306 1 1 1 1 90 0 2.5 8 8 0 2 
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132 RADHIKA 224317 20 2 271 1.68 2 250 4 4 258 1 1 1 1 60 0 2.4 9 9 0 2 
133 SUGANYA 224322 20 0 272 1.22 1 330 30 5 365 1 1 1 1 90 0 2.6 7 8 0 1 
134 SATHYA 224390 23 1 261 1.65 1 255 23 5 283 1 1 1 1 170 1 2.5 8 9 0 0 
135 CHANDRALEKHA 224480 20 0 261 1.40 1 300 25 5 330 1 1 1 1 180 0 2.75 9 8 0 1 
136 REENA 224522 24 1 269 1.71 1 245 50 4 299 2 1 1 1 210 0 2.8 8 8 0 1 
137 PARIMALA 224569 27 0 262 1.91 1 220 20 5 245 1 1 1 1 110 0 2.6 9 9 0 2 
138 KANAGAVALLI 224727 19 1 271 1.68 1 250 25 4 279 1 1 1 1 125 0 2 8 9 0 1 
139 RATHI 224821 22 0 271 1.45 1 290 22 4 316 1 1 1 1 100 0 2.4 86 9 0 2 
140 NEELAVATHI 224853 23 1 270 
 
1 _ 
 
3 
 
3 1 1 1 350 0 2.95 8 7 0 1 
141 SURYA 224855 21 1 282 3.00 2 140 18 4 162 1 1 1 1 130 0 2.75 8 9 0 1 
142 RAHIMUNISH 224856 30 2 260 3.00 1 140 20 4 164 1 1 1 1 120 0 2.8 8 9 0 1 
143 SUDHA 225548 22 1 266 1.47 1 285 24 5.3 314.3 1 1 1 1 180 0 3 9 9 0 0 
144 JEYANTHI 224965 23 1 275 1.18 1 355 30 4 389 1 1 1 1 150 0 3 7 9 0 1 
145 RATHIKA 225096 23 0 280 
 
1 _ 
 
3 
 
3 1 1 1 275 0 2.3 7 8 0 2 
146 SIVARANJANI 224915 18 1 270 1.56 1 270 24 4 298 1 1 1 1 80 0 2.9 8 8 0 1 
147 ISWARYA 225334 22 2 281 2.43 1 173 17 4 194 1 1 1 1 90 0 3 8 9 0 2 
148 NATHIYA 225660 25 0 266 1.79 1 235 20 5 260 1 1 1 1 150 1 2.5 8 9 0 0 
149 ARULJOTHI 226106 25 0 274 1.33 1 315 25 4 344 1 1 1 1 95 0 3.25 8 9 0 0 
150 VARALAKSHMI 225712 24 1 266 1.75 1 240 20 4 264 1 1 1 1 140 0 2.81 8 9 0 1 
 
 
 
 
 
 
 
 
 Pain Relief Score 
0- No Pain relief 
1- Mild Pain Relief 
2- Moderate Pain Relief 
3- Excellent Pain Relief 
Mode of Onset of Labour 
1- Spontaneous 
2- Induced 
Liquor Colour 
1- Clear 
2- Meconium 
3- Blood stained 
Ability to cooperative at 2nd stage 
1- Able 
2- Not able 
 
 
 
 
 
 
Maternal Complication 
0- No 
1- Nausea/vomiting 
2- Tachycardia 
3- Drowsiness 
4- Dryness of mouth 
5- Hypersalivation 
 
NICU admission 
0- not admitted 
1- admitted 
Maternal satisfaction score 
0-   Unsatisfied 
1-2  Just satisfied 
3 -4  Good satisfaction 
5        Excellent Satisfaction 
GA    Gestational Age 
MOD  Mode Of Delivery 
RCD   Rate of Cervical Dilatation 
KEY TO MASTER CHART 
 
